<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">JAMA Netw Open</journal-id><journal-id journal-id-type="iso-abbrev">JAMA Netw Open</journal-id><journal-title-group><journal-title>JAMA Network Open</journal-title></journal-title-group><issn pub-type="epub">2574-3805</issn><publisher><publisher-name>American Medical Association</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39998828</article-id><article-id pub-id-type="pmc">PMC11862974</article-id>
<article-id pub-id-type="doi">10.1001/jamanetworkopen.2024.61795</article-id><article-id pub-id-type="publisher-id">zoi241717</article-id><article-categories><subj-group subj-group-type="category" specific-use="electronic"><subject>Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Investigation</subject></subj-group><subj-group subj-group-type="online-only"><subject>Online Only</subject></subj-group><subj-group subj-group-type="subject-area"><subject>Pediatrics</subject></subj-group></article-categories><title-group><article-title>Cardiopulmonary Fitness and Physical Activity Among Children and Adolescents With Inherited Cardiac Disease</article-title><alt-title alt-title-type="headline">Cardiopulmonary Fitness and Physical Activity in Pediatric Inherited Cardiac Disease</alt-title><alt-title alt-title-type="running-head">Cardiopulmonary Fitness and Physical Activity in Pediatric Inherited Cardiac Disease</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Souilla</surname><given-names>Luc</given-names></name><degrees>PhD</degrees><xref rid="zoi241717aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="zoi241717aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Werner</surname><given-names>Oscar</given-names></name><degrees>MD</degrees><xref rid="zoi241717aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Huguet</surname><given-names>Helena</given-names></name><degrees>MSc</degrees><xref rid="zoi241717aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Gavotto</surname><given-names>Arthur</given-names></name><degrees>MD</degrees><degrees>PhD</degrees><xref rid="zoi241717aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="zoi241717aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Vincenti</surname><given-names>Marie</given-names></name><degrees>MD</degrees><xref rid="zoi241717aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="zoi241717aff2" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Pasquie</surname><given-names>Jean-Luc</given-names></name><degrees>MD</degrees><degrees>PhD</degrees><xref rid="zoi241717aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="zoi241717aff4" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>De La Villeon</surname><given-names>Gregoire</given-names></name><degrees>MD</degrees><xref rid="zoi241717aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="zoi241717aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Guillaumont</surname><given-names>Sophie</given-names></name><degrees>MD</degrees><xref rid="zoi241717aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="zoi241717aff5" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Pommier</surname><given-names>Victor</given-names></name><degrees>MD</degrees><xref rid="zoi241717aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="zoi241717aff5" ref-type="aff">
<sup>5</sup>
</xref><xref rid="zoi241717aff6" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Matecki</surname><given-names>Stefan</given-names></name><degrees>MD</degrees><degrees>PhD</degrees><xref rid="zoi241717aff1" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Baruteau</surname><given-names>Alban-Elouen</given-names></name><degrees>MD</degrees><degrees>PhD</degrees><xref rid="zoi241717aff7" ref-type="aff">
<sup>7</sup>
</xref><xref rid="zoi241717aff8" ref-type="aff">
<sup>8</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Beyler</surname><given-names>Constance</given-names></name><degrees>MD</degrees><xref rid="zoi241717aff9" ref-type="aff">
<sup>9</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Delclaux</surname><given-names>Christophe</given-names></name><degrees>MD</degrees><degrees>PhD</degrees><xref rid="zoi241717aff9" ref-type="aff">
<sup>9</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Denjoy</surname><given-names>Isabelle</given-names></name><degrees>MD</degrees><xref rid="zoi241717aff10" ref-type="aff">
<sup>10</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Charron</surname><given-names>Philippe</given-names></name><degrees>MD</degrees><degrees>PhD</degrees><xref rid="zoi241717aff10" ref-type="aff">
<sup>10</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Chevalier</surname><given-names>Philippe</given-names></name><degrees>MD</degrees><degrees>PhD</degrees><xref rid="zoi241717aff11" ref-type="aff">
<sup>11</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Delini&#x000e8;re</surname><given-names>Antoine</given-names></name><degrees>MD</degrees><xref rid="zoi241717aff11" ref-type="aff">
<sup>11</sup>
</xref><xref rid="zoi241717aff12" ref-type="aff">
<sup>12</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Andrianoely</surname><given-names>Mathieu</given-names></name><degrees>BSc</degrees><xref rid="zoi241717aff13" ref-type="aff">
<sup>13</sup>
</xref><xref rid="zoi241717aff14" ref-type="aff">
<sup>14</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Cornuault</surname><given-names>Lauriane</given-names></name><degrees>PharmD</degrees><degrees>PhD</degrees><xref rid="zoi241717aff13" ref-type="aff">
<sup>13</sup>
</xref><xref rid="zoi241717aff14" ref-type="aff">
<sup>14</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Besnard-Neyraud</surname><given-names>Caroline</given-names></name><degrees>MD</degrees><degrees>PhD</degrees><xref rid="zoi241717aff13" ref-type="aff">
<sup>13</sup>
</xref><xref rid="zoi241717aff14" ref-type="aff">
<sup>14</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Sacher</surname><given-names>Frederic</given-names></name><degrees>MD</degrees><degrees>PhD</degrees><xref rid="zoi241717aff14" ref-type="aff">
<sup>14</sup>
</xref><xref rid="zoi241717aff15" ref-type="aff">
<sup>15</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Reant</surname><given-names>Patricia</given-names></name><degrees>MD</degrees><degrees>PhD</degrees><xref rid="zoi241717aff14" ref-type="aff">
<sup>14</sup>
</xref><xref rid="zoi241717aff16" ref-type="aff">
<sup>16</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Mottet</surname><given-names>Denis</given-names></name><degrees>MD</degrees><degrees>PhD</degrees><xref rid="zoi241717aff17" ref-type="aff">
<sup>17</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Picot</surname><given-names>Marie-Christine</given-names></name><degrees>MD</degrees><degrees>PhD</degrees><xref rid="zoi241717aff3" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Amedro</surname><given-names>Pascal</given-names></name><degrees>MD</degrees><degrees>PhD</degrees><xref rid="zoi241717aff13" ref-type="aff">
<sup>13</sup>
</xref><xref rid="zoi241717aff14" ref-type="aff">
<sup>14</sup>
</xref></contrib><on-behalf-of>for the Quality of Life in Children With Inherited Cardiomyopathy or Arrhythmia (QUALIMYORYTHM) Study Group</on-behalf-of></contrib-group><aff id="zoi241717aff1"><label>1</label>PhyMedExp, INSERM, CNRS, University of Montpellier, Montpellier, France</aff><aff id="zoi241717aff2"><label>2</label>Department of Pediatric and Congenital Cardiology, M3C Regional Reference Centre, Montpellier University Hospital, Montpellier, France</aff><aff id="zoi241717aff3"><label>3</label>Epidemiology and Clinical Research Department, Montpellier University Hospital, University of Montpellier, Montpellier, France</aff><aff id="zoi241717aff4"><label>4</label>Cardiology and Vascular Diseases Department, Regional Reference Centre for Inherited Cardiac Arrhythmia, Montpellier University Hospital, Montpellier, France</aff><aff id="zoi241717aff5"><label>5</label>Pediatric Cardiology and Rehabilitation Unit, Institut-Saint-Pierre, Palavas-Les-Flots, France</aff><aff id="zoi241717aff6"><label>6</label>Department of Pediatric and Congenital Cardiology, CHU La Reunion, University of La Reunion, Saint-Denis, France</aff><aff id="zoi241717aff7"><label>7</label>Nantes Universit&#x000e9;, CHU Nantes, Department of Pediatric Cardiology and Pediatric Cardiac Surgery, FHU PreciCare, Nantes, France</aff><aff id="zoi241717aff8"><label>8</label>Nantes Universit&#x000e9;, CHU Nantes, INSERM, CIC FEA 1413, CNRS, INSERM, l&#x02019;institut du Thorax, INRAE, UMR 1280, PhAN, Nantes, France</aff><aff id="zoi241717aff9"><label>9</label>Pediatric Cardiology and Physiology Department, Robert Debre University Hospital, APHP, Paris, France</aff><aff id="zoi241717aff10"><label>10</label>Department of Cardiology, National Reference Centre for Inherited Cardiac Disease, APHP, Paris, France</aff><aff id="zoi241717aff11"><label>11</label>National Reference Centre for Inherited Arrhythmia of Lyon (CERA), Electrophysiology Unit, H&#x000f4;pital Cardiologique Louis Pradel, Hospices Civils de Lyon, Bron, France</aff><aff id="zoi241717aff12"><label>12</label>Claude Bernard Lyon 1 University, MeLiS, CNRS UMR 5284, INSERM U1314, Institut NeuroMyoG&#x000e8;ne, Lyon, France</aff><aff id="zoi241717aff13"><label>13</label>Department of Pediatric and Adult Congenital Cardiology, National Reference Centre for Complex Congenital Heart Disease, Bordeaux University Hospital, Pessac, France</aff><aff id="zoi241717aff14"><label>14</label>IHU Liryc, Electrophysiology and Heart Modelling Institute, INSERM U1045, University of Bordeaux, Pessac, France</aff><aff id="zoi241717aff15"><label>15</label>National Reference Centre for Inherited Cardiac Arrhythmia, CMARY, ERN Guard-Heart, Bordeaux University Hospital, Pessac, France</aff><aff id="zoi241717aff16"><label>16</label>National Reference Centre for Inherited Cardiomyopathy, Bordeaux University Hospital, Pessac, France</aff><aff id="zoi241717aff17"><label>17</label>EuroMov Digital Health in Motion, University of Montpellier, IMT Mines Al&#x000e8;s, Montpellier, France</aff><author-notes><title>Article Information</title><p><bold>Accepted for Publication:</bold> November 27, 2024.</p><p content-type="published-online"><bold>Published:</bold> February 25, 2025. doi:<uri content-type="doi">10.1001/jamanetworkopen.2024.61795</uri></p><p content-type="open-access-note"><bold>Open Access:</bold> This is an open access article distributed under the terms of the <ext-link xlink:href="https://jamanetwork.com/pages/cc-by-license-permissions" ext-link-type="uri">CC-BY License</ext-link>. &#x000a9; 2025 Souilla L et al. <italic>JAMA Network Open</italic>.</p><corresp id="zoi241717cor1"><bold>Corresponding Author:</bold> Pascal Amedro, MD, PhD, Department of Pediatric and Adult Congenital Cardiology, M3C National Reference Centre for Complex Congenital Heart Disease, Bordeaux University Hospital, Haut-L&#x000e9;v&#x000ea;que Hospital, Avenue de Magellan, 33604 Pessac Cedex, France (<email xlink:href="pascal.amedro@gmail.com">pascal.amedro@gmail.com</email>).</corresp><p content-type="author-contributions"><bold>Author Contributions:</bold> Drs Picot and Amedro had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.</p><p><italic>Concept and design:</italic> Souilla, Pasquie, Guillaumont, Pommier, Matecki, Charron, Picot, Amedro.</p><p><italic>Acquisition, analysis, or interpretation of data:</italic> Souilla, Werner, Huguet, Gavotto, Vincenti, Pasquie, De La Villeon, Guillaumont, Pommier, Baruteau, Beyler, Delclaux, Denjoy, Chevalier, Delini&#x000e8;re, Andrianoely, Cornuault, Besnard-Neyraud, Sacher, Reant, Mottet, Picot, Amedro.</p><p><italic>Drafting of the manuscript:</italic> Souilla, Werner, Pasquie, Pommier, Mottet, Amedro.</p><p><italic>Critical review of the manuscript for important intellectual content:</italic> Souilla, Huguet, Gavotto, Vincenti, Pasquie, De La Villeon, Guillaumont, Matecki, Baruteau, Beyler, Delclaux, Denjoy, Charron, Chevalier, Delini&#x000e8;re, Andrianoely, Cornuault, Besnard-Neyraud, Sacher, Reant, Mottet, Picot, Amedro.</p><p><italic>Statistical analysis:</italic> Souilla, Huguet, Picot.</p><p><italic>Obtained funding:</italic> Souilla, Werner, Besnard-Neyraud, Amedro.</p><p><italic>Administrative, technical, or material support:</italic> Souilla, Gavotto, Vincenti, Pasquie, Guillaumont, Matecki, Delclaux, Andrianoely, Reant, Picot, Amedro.</p><p><italic>Supervision:</italic> Souilla, Pasquie, De La Villeon, Guillaumont, Beyler, Denjoy, Charron, Chevalier, Delini&#x000e8;re, Besnard-Neyraud, Sacher, Mottet, Amedro.</p><p content-type="COI-statement"><bold>Conflict of Interest Disclosures:</bold> Dr Charron reported receiving personal fees from Amicus Therapeutics, Bristol Myers Squibb, Owkin, and Pfizer outside the submitted work. Dr Delini&#x000e8;re reported receiving personal fees from Sanofi, Bristol Myers Squibb, and Anlylam Pharmaceuticals outside the submitted work. Dr Sacher reported receiving personal fees from Abbott, Biosense Webster, Boston Scientific, Medtronic, and inHEART outside the submitted work. No other disclosures were reported.</p><p content-type="funding-statement"><bold>Funding/Support:</bold> The study was funded by the National Department of Health (grant DGOS-GIRCI-SOHO-APITHEM-2019), the Fondation de France (grant Caring, relieving, accompanying: 2021 research projects), the French Federation of Cardiology (FFC; 2019 FFC research team), the French National Rare Cardiovascular Disease Network (2018 CARDIOGEN call for proposal), the University of Montpellier (Chemical and Biological Sciences for Health [CBS2] doctoral award), and Montpellier University Hospital (2019 Young Researcher Award). Researchers were supported by the French Government as part of the Investments in the Future program managed by the National Research Agency (ANR), grant reference ANR-10-IAHU-04.</p><p><bold>Role of the Funder/Sponsor:</bold> The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</p><p><bold>Group Information:</bold> The members of the Quality of Life in Children With Inherited Cardiomyopathy or Arrhythmia (QUALIMYORYTHM) Study Group are listed in <xref rid="note-ZOI241717-1-s" ref-type="supplementary-material">Supplement 2</xref>.</p><p content-type="data-sharing-statement"><bold>Data Sharing Statement:</bold> See <xref rid="note-ZOI241717-1-s" ref-type="supplementary-material">Supplement 3</xref>.</p><p><bold>Additional Contributions:</bold> We thank all the patients who participated in the study. We are grateful to CARDIOGEN for their support. We also thank patients advocacy organization delegates Sophie Pierre, AMRYC (Association des Patients Atteints de Maladies du Rythme Cardiaque), and Lea Falloud, Ligue Contre la Cardiomyopathie, for their encouragement in carrying out the study.</p></author-notes><pub-date pub-type="epub" iso-8601-date="2025-02-25T10:00"><day>25</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>25</day><month>2</month><year>2025</year></pub-date><!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.--><volume>8</volume><issue>2</issue><elocation-id>e2461795</elocation-id><history><date date-type="received"><day>9</day><month>8</month><year>2024</year></date><date date-type="accepted"><day>27</day><month>11</month><year>2024</year></date></history><permissions><copyright-statement>Copyright 2025 Souilla L et al. <italic>JAMA Network Open</italic>.</copyright-statement><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the CC-BY License.</license-p></license></permissions><self-uri content-type="pdf-version" xlink:href="jamanetwopen-e2461795.pdf">jamanetwopen-e2461795.pdf</self-uri><self-uri content-type="silverchair" xlink:href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2024.61795"/><related-article related-article-type="commentary" ext-link-type="doi" id="ZIC240381" xlink:href="10.1001/jamanetworkopen.2024.61800"/><abstract abstract-type="key-points"><title>Key Points</title><sec id="ab-zoi241717-1"><title>Question</title><p>What are the levels of cardiopulmonary fitness among children and adolescents with inherited cardiac disease compared with healthy controls and the factors associated with maximum oxygen uptake (&#x00056;&#x00307;<sc>o</sc><sub>2</sub>max) in young patients?</p></sec><sec id="ab-zoi241717-2"><title>Findings</title><p>This cross-sectional study with 207 participants showed lower levels of cardiopulmonary fitness among youths with inherited cardiac disease. The multivariable model explained 80% of &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max, including clinical, functional, sociodemographic, and behavioral parameters.</p></sec><sec id="ab-zoi241717-3"><title>Meaning</title><p>This study suggests that assessing cardiopulmonary fitness among children with inherited cardiac disease can be incorporated into the shared decision-making process for sports participation and may help identify eligible patients for early preventive cardiac rehabilitation programs.</p></sec></abstract><abstract><sec id="ab-zoi241717-4"><title>Importance</title><p>Historical restrictions on children with inherited cardiac arrhythmia or cardiomyopathy have been implemented to mitigate the potential risk of sudden death, but these limitations can be detrimental to overall health and cardiopulmonary fitness.</p></sec><sec id="ab-zoi241717-5"><title>Objectives</title><p>To evaluate cardiopulmonary fitness and physical activity among children with inherited cardiac disease and identify the factors associated with maximum oxygen uptake (&#x00056;&#x00307;<sc>o</sc><sub>2</sub>max) in this population.</p></sec><sec id="ab-zoi241717-6"><title>Design, Setting, and Participants</title><p>This cross-sectional, multicenter, prospective controlled study was conducted in 7 tertiary care expert centers for inherited cardiac disease in France from February 1, 2021, to June 20, 2023, with a 2-week follow-up. Participants included 100 children and adolescents aged 6 to 17 years with inherited cardiac arrhythmia or cardiomyopathy who were compared with 107 sex- and age-matched controls.</p></sec><sec id="ab-zoi241717-7"><title>Main Outcomes and Measures</title><p>Maximum oxygen uptake was assessed using cardiopulmonary exercise testing, and results were expressed using pediatric reference <italic>z</italic> score values. The main determinants of &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max included clinical (New York Heart Association [NYHA] functional class, treatment, echocardiographic, and electrocardiogram variables), functional (cardiopulmonary exercise test parameters), sociodemographic (sex, schooling, and parents&#x02019; education), and behavioral (physical activity and motivation) characteristics.</p></sec><sec id="ab-zoi241717-8"><title>Results</title><p>A total of 100 patients (mean [SD] age, 12.7 [3.1] years; 52 boys [52.0%]) and 107 controls (mean [SD] age, 11.7 [3.3] years; 54 boys [50.5%]) were included. The &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max was lower in patients than controls, expressed as <italic>z</italic> scores (mean [SD] score, &#x02212;1.49 [1.48] vs &#x02212;0.16 [0.97]; <italic>P</italic>&#x02009;&#x0003c;&#x02009;.001) or raw values (mean [SD] value, 32.2 [7.9] vs 40.2 [8.5] mL/kg/min; <italic>P</italic>&#x02009;&#x0003c;&#x02009;.001). Moderate to vigorous physical activity levels were lower in patients than in controls (mean [SD] level, 42.0 [23.6] vs 48.2 [20.4] min/d; <italic>P</italic>&#x02009;=&#x02009;.009). The final multivariable model explained 80% of the &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max by integrating clinical (lower NYHA functional class, absence of ventricular dilatation, and absence of implantable cardioverter-defibrillator), functional (higher forced vital capacity and ventilatory anaerobic threshold), sociodemographic (male sex, normal progression of schooling, and higher maternal educational level), and behavioral (higher self-reported physical activity and motivation toward physical activity) parameters.</p></sec><sec id="ab-zoi241717-9"><title>Conclusions and Relevance</title><p>This cross-sectional study suggests that levels of cardiopulmonary fitness and physical activity were lower in children and adolescents with inherited cardiac disease than in healthy controls, even after adjusting for use of &#x003b2;-blockers and using modern pediatric reference models. Assessing cardiopulmonary fitness among children with inherited cardiac disease can contribute to engaging in a shared decision-making process for sports participation and preventive interventions, such as early cardiac rehabilitation programs.</p></sec></abstract><abstract abstract-type="teaser" specific-use="electronic"><p>This cross-sectional study evaluates cardiopulmonary fitness and physical activity among children with inherited cardiac disease vs controls and identifies the factors associated with maximum oxygen uptake in this population.</p></abstract></article-meta></front><body><sec id="H1-1-ZOI241717"><title>Introduction</title><p>Cardiopulmonary fitness is an important marker of health<sup><xref rid="zoi241717r1" ref-type="bibr">1</xref>,<xref rid="zoi241717r2" ref-type="bibr">2</xref></sup> associated with quality of life among children with cardiac conditions.<sup><xref rid="zoi241717r3" ref-type="bibr">3</xref></sup> Cardiopulmonary exercise testing (CPET) has become a key examination in various pediatric preventive cardiology programs.<sup><xref rid="zoi241717r4" ref-type="bibr">4</xref>,<xref rid="zoi241717r5" ref-type="bibr">5</xref></sup> Cardiopulmonary fitness decreases 4 times faster in children with congenital heart disease than in the healthy population,<sup><xref rid="zoi241717r6" ref-type="bibr">6</xref></sup> resulting in a higher risk of myocardial infarction and chronic cardiovascular disease later in life.<sup><xref rid="zoi241717r7" ref-type="bibr">7</xref>,<xref rid="zoi241717r8" ref-type="bibr">8</xref>,<xref rid="zoi241717r9" ref-type="bibr">9</xref></sup> Given these risks, a preventive approach through early cardiac rehabilitation has demonstrated benefits on cardiopulmonary fitness and quality of life for children with congenital heart disease.<sup><xref rid="zoi241717r4" ref-type="bibr">4</xref>,<xref rid="zoi241717r10" ref-type="bibr">10</xref></sup></p><p>Apart from congenital heart disease, other life-threatening pediatric cardiac conditions, such as inherited arrhythmias or cardiomyopathies, have received far less attention regarding preventive interventions. However, patients with these conditions face barriers to engaging in physical activities due to parental overprotection, lack of self-efficacy, and fear of cardiac events.<sup><xref rid="zoi241717r11" ref-type="bibr">11</xref>,<xref rid="zoi241717r12" ref-type="bibr">12</xref>,<xref rid="zoi241717r13" ref-type="bibr">13</xref></sup> In addition, concerns about mortality risks associated with sports participation have led physicians to impose long-standing restrictions despite limited supporting evidence.<sup><xref rid="zoi241717r14" ref-type="bibr">14</xref>,<xref rid="zoi241717r15" ref-type="bibr">15</xref>,<xref rid="zoi241717r16" ref-type="bibr">16</xref></sup> More recent studies challenge these assumptions, instead promoting shared decision-making to empower patients with accurate information and support their autonomy in deciding whether to engage in sports.<sup><xref rid="zoi241717r17" ref-type="bibr">17</xref>,<xref rid="zoi241717r18" ref-type="bibr">18</xref>,<xref rid="zoi241717r19" ref-type="bibr">19</xref>,<xref rid="zoi241717r20" ref-type="bibr">20</xref></sup></p><p>However, implementing shared decision-making to minimize the risk of cardiac events among children with inherited cardiac disease remains challenging. Beyond the cardiologic phenotype and genotype, a comprehensive evaluation of cardiopulmonary fitness and physical activity would enable professionals to ascertain individual exercise capacities and recommend appropriate intensities and modalities. By being fully informed of their specific fitness and physical activity levels, patients may effectively participate in the decision-making process.<sup><xref rid="zoi241717r18" ref-type="bibr">18</xref></sup> Previous reports on pediatric inherited cardiac disease indicated limitations in cardiopulmonary fitness and physical activity. However, these investigations lacked control groups, involved small sample sizes,<sup><xref rid="zoi241717r11" ref-type="bibr">11</xref>,<xref rid="zoi241717r21" ref-type="bibr">21</xref>,<xref rid="zoi241717r22" ref-type="bibr">22</xref>,<xref rid="zoi241717r23" ref-type="bibr">23</xref>,<xref rid="zoi241717r24" ref-type="bibr">24</xref>,<xref rid="zoi241717r25" ref-type="bibr">25</xref>,<xref rid="zoi241717r26" ref-type="bibr">26</xref></sup> and did not use contemporary and reliable pediatric CPET reference values.<sup><xref rid="zoi241717r27" ref-type="bibr">27</xref>,<xref rid="zoi241717r28" ref-type="bibr">28</xref></sup></p><p>This multicenter, prospective, controlled cross-sectional study aimed to evaluate cardiopulmonary fitness and physical activity among children and adolescents with inherited cardiac disease compared with healthy controls using contemporary pediatric <italic>z</italic> scores. We hypothesized that these markers of physical health would be affected in this population, in association with various factors other than the underlying cardiac disease.</p></sec><sec id="H1-2-ZOI241717"><title>Methods</title><sec id="H2-1-ZOI241717"><title>Study Design and Settings</title><p>This prospective, multicenter, controlled cross-sectional study was conducted from February 1, 2021, to June 20, 2023, with a 2-week follow-up, in 7 French pediatric university hospitals (expert centers for inherited cardiac disease). The study was conducted following the Good Clinical Practice principles and the Declaration of Helsinki<sup><xref rid="zoi241717r29" ref-type="bibr">29</xref></sup> after receiving ethical approval from Comit&#x000e9; de Protection des Personnes Sud-Est-VI and preregistration at ClinicalTrials.gov (<ext-link xlink:href="https://clinicaltrials.gov/study/NCT04712136" ext-link-type="uri">NCT04712136</ext-link>). Written informed consent was obtained from all parents or legal guardians, and oral assent was obtained from all children. The study design was previously published<sup><xref rid="zoi241717r30" ref-type="bibr">30</xref></sup> and followed the Strengthening the Reporting of Observational Studies in Epidemiology (<ext-link xlink:href="http://www.equator-network.org/reporting-guidelines/strobe/" ext-link-type="uri">STROBE</ext-link>) reporting guideline.<sup><xref rid="zoi241717r31" ref-type="bibr">31</xref></sup></p></sec><sec id="H2-2-ZOI241717"><title>Participants</title><p>Children and adolescents aged 6 to 17 years who received a clinical or genetic diagnosis of an inherited cardiac arrhythmia (long QT syndrome, Brugada syndrome, or catecholaminergic polymorphic ventricular tachycardia) or an inherited cardiomyopathy (hypertrophic, dilated, or restrictive cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy) were prospectively recruited during a routine outpatient cardiology consultation. Healthy controls (aged 6-17 years) were consecutively referred for CPET with nonsevere functional symptoms (eg, murmur, palpitation, or dyspnea). Participants with normal cardiologic checkup results (physical examination, electrocardiography [ECG], and echocardiography), no chronic disease (eg, pulmonary, kidney, or neurologic), and no long-term medication were eligible for inclusion in the control group. Patients whose CPET results indicated cardiologic abnormalities requiring further investigation (eg, abnormal ECG results or blood pressure) were not eligible. Participants who were not able to answer the questionnaires independently or with assistance from a clinical research associate (eg, non-French speakers) were not eligible.</p></sec><sec id="H2-3-ZOI241717"><title>Cardiopulmonary Fitness</title><p>Cardiopulmonary fitness was evaluated using a unified pediatric cycle ergometer CPET protocol consistent with previous studies (details are provided in the eAppendix in <xref rid="note-ZOI241717-1-s" ref-type="supplementary-material">Supplement 1</xref>).<sup><xref rid="zoi241717r6" ref-type="bibr">6</xref>,<xref rid="zoi241717r27" ref-type="bibr">27</xref></sup> The main parameter reflecting cardiopulmonary fitness was the maximum oxygen uptake (&#x00056;&#x00307;<sc>o</sc><sub>2</sub>max), an important marker of health.<sup><xref rid="zoi241717r2" ref-type="bibr">2</xref>,<xref rid="zoi241717r32" ref-type="bibr">32</xref></sup> The study primary outcome was &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max expressed as a <italic>z</italic> score from the recent pediatric CPET reference equations, derived from a nonlinear model using natural logarithms of &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max, height, and body mass index (BMI; calculated as weight in kilograms divided by height in meters squared).<sup><xref rid="zoi241717r27" ref-type="bibr">27</xref>,<xref rid="zoi241717r28" ref-type="bibr">28</xref></sup></p><p>Other CPET parameters were collected, including the ventilatory anaerobic threshold (VAT) estimated using the V-slope method,<sup><xref rid="zoi241717r33" ref-type="bibr">33</xref></sup> ventilatory efficiency, oxygen uptake efficiency slope, and maximum oxygen pulse. One investigator per center interpreted CPET, and parameters were expressed in <italic>z</italic> scores from the same pediatric CPET reference equations.<sup><xref rid="zoi241717r27" ref-type="bibr">27</xref>,<xref rid="zoi241717r28" ref-type="bibr">28</xref></sup> Impaired &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max and VAT were defined as a <italic>z</italic> score less than &#x02212;1.64, corresponding to the fifth percentile for standard normal distribution.<sup><xref rid="zoi241717r27" ref-type="bibr">27</xref>,<xref rid="zoi241717r28" ref-type="bibr">28</xref></sup></p><p>For didactic purposes, as most results in previous pediatric CPET studies have been presented using raw values or historic linear reference models, &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max and VAT were also expressed in milliliters per kilogram per minute and as a percentage of the estimated value from the weight-based equations of Cooper et al.<sup><xref rid="zoi241717r34" ref-type="bibr">34</xref></sup> A &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max of less than 80% or a VAT of less than 55% indicated impaired cardiopulmonary fitness using the equations of Cooper et al.<sup><xref rid="zoi241717r4" ref-type="bibr">4</xref>,<xref rid="zoi241717r34" ref-type="bibr">34</xref></sup></p></sec><sec id="H2-4-ZOI241717"><title>Physical Activity</title><p>An accelerometer (ActiGraph GT3X; ActiGraph LLC) was placed on the child&#x02019;s right hip to measure daily physical activity.<sup><xref rid="zoi241717r35" ref-type="bibr">35</xref></sup> Instructions were given to continuously wear it for 14 days, excluding the time spent sleeping, and intensities were classified according to thresholds of Evenson et al.<sup><xref rid="zoi241717r36" ref-type="bibr">36</xref></sup> Participants&#x02019; data were deemed valid if they wore the accelerometer for at least 3 days with a minimum of 10 hours per day.<sup><xref rid="zoi241717r37" ref-type="bibr">37</xref></sup></p><p>Children also completed 2 questionnaires under the clinical research assistant&#x02019;s supervision: the Ricci and Gagnon physical activity questionnaire<sup><xref rid="zoi241717r38" ref-type="bibr">38</xref></sup> and the Motivation for Health-Oriented Physical Activity questionnaire.<sup><xref rid="zoi241717r39" ref-type="bibr">39</xref></sup> Details on physical activity assessment are provided in the eAppendix in <xref rid="note-ZOI241717-1-s" ref-type="supplementary-material">Supplement 1</xref>.</p></sec><sec id="H2-5-ZOI241717"><title>Other Data Collected</title><p>In both groups, the following sociodemographic characteristics, collected through a survey, and clinical data were as follows: age, sex, BMI, New York Heart Association (NYHA) functional class, 2-dimensional ECG parameters, 12-lead electrocardiographic variables, and information on patients&#x02019; family situations, parents&#x02019; employment, and child&#x02019;s school curriculum. Inherited cardiac disease&#x02013;related data included age at diagnosis, prior symptoms, genetics, disease severity and type, medications, pacemaker, implantable cardioverter-defibrillator, and prior cardiac surgical procedures.</p></sec><sec id="H2-6-ZOI241717"><title>Sample Size</title><p>The Quality of Life in Children With Inherited Cardiomyopathy or Arrhythmia (QUALIMYORYTHM) trial was designed to compare health-related quality of life among children with inherited cardiac disease vs healthy children (primary outcome) and evaluate cardiopulmonary fitness and physical activity (secondary outcomes).<sup><xref rid="zoi241717r30" ref-type="bibr">30</xref></sup> Based on previous studies, we hypothesized to observe a mean (SD) difference in the total PedsQL (Pediatric Quality of Life Inventory) of 7 (15) points.<sup><xref rid="zoi241717r40" ref-type="bibr">40</xref>,<xref rid="zoi241717r41" ref-type="bibr">41</xref></sup> With a 90% power, a 5% bilateral &#x003b1; risk, and potentially 10% loss to follow-up or missing data on the primary outcome, a total of 214 patients were required (107 in each group).<sup><xref rid="zoi241717r42" ref-type="bibr">42</xref>,<xref rid="zoi241717r43" ref-type="bibr">43</xref>,<xref rid="zoi241717r44" ref-type="bibr">44</xref></sup> This sample size exceeds the minimum number of 138 participants required to observe a &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max mean (SD) relevant difference of 5.5 (9.4) mL/kg/min, using a 2-sided &#x003b1; risk of 5%, 90% power, and 10% attrition rate, based on previous studies.<sup><xref rid="zoi241717r6" ref-type="bibr">6</xref>,<xref rid="zoi241717r21" ref-type="bibr">21</xref>,<xref rid="zoi241717r28" ref-type="bibr">28</xref></sup></p></sec><sec id="H2-7-ZOI241717"><title>Statistical Analysis</title><p>The study population was described with mean (SD) values for quantitative variables and with numbers and percentages for qualitative variables. Continuous variable distributions were tested using the Shapiro-Wilk test. Quantitative variables were compared using the <italic>t</italic> test when the distribution was Gaussian and the Mann-Whitney test otherwise. For qualitative variables, the groups were compared using the &#x003c7;<sup>2</sup> test or the Fisher exact test.</p><p>For comparisons of CPET parameters, a covariate analysis adjusted for &#x003b2;-blocker treatment, and BMI was used to account for their potential association (only for &#x003b2;-blocker treatment for <italic>z</italic> scores, as BMI is included in the model). The effect size was estimated using the absolute difference in mean values or frequencies with a 95% CI.</p><p>To identify the factors associated with &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max <italic>z</italic> score among children with inherited cardiac disease, a multiple linear regression model was used. When potential factors were considered missing at random, a multiple linear imputation was implemented using a fully conditional specification method. For better stability, the number of imputations in the imputation process was 10, and all baseline characteristics were used in the imputation model. The percentage of missing data for main factors varied between 3% and 10%. All clinically relevant parameters (functional, clinical, sociodemographic, and behavioral) with <italic>P</italic>&#x02009;&#x02264;&#x02009;.20 in the univariate analysis were included in the model. Variables were selected using backward selection based on the Akaike information criterion. No collinearity between variables was detected with variance inflation factors. The normality of residues in the final model was tested using the Shapiro-Wilk test. All <italic>P</italic> values were from 2-sided tests, and results were deemed statistically significant at <italic>P</italic>&#x02009;&#x0003c;&#x02009;.05. Analyses were performed using SAS, version 9.04 (SAS Institute Inc).</p></sec></sec><sec id="H1-3-ZOI241717"><title>Results</title><sec id="H2-8-ZOI241717"><title>Population Characteristics</title><p>The total expected number of 214 participants were enrolled in the study, but 6 children with inherited cardiac disease and 1 in the control group were unable to undergo CPET (eFigure in <xref rid="note-ZOI241717-1-s" ref-type="supplementary-material">Supplement 1</xref>). Therefore, the final analysis included 207 participants: 100 patients (mean [SD] age, 12.7 [3.1] years; 52 boys [52.0%] and 48 girls [48.0%]) and 107 controls (mean [SD] age, 11.7 [3.3] years; 54 boys [50.5%] and 53 girls [49.5%]) (<xref rid="zoi241717t1" ref-type="table">Table 1</xref>). Both groups were similar in terms of sex and age; however, children with inherited cardiac disease were taller, heavier, and had a moderately higher BMI and a lower resting heart rate than healthy controls. A higher proportion of unemployed mothers was observed in the patient group, and children&#x02019;s parents were more likely to be employees than higher intellectual or intermediate professionals.</p><table-wrap position="float" id="zoi241717t1"><label>Table 1. </label><caption><title>Population Characteristics</title></caption><table frame="hsides" rules="groups"><col width="53.62%" span="1"/><col width="17.23%" span="1"/><col width="19.53%" span="1"/><col width="9.62%" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Characteristic</th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Participants, No./total No. (%)</th><th rowspan="2" valign="top" align="left" scope="col" colspan="1"><italic>P</italic> value</th></tr><tr><th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Patients (n&#x02009;=&#x02009;100)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Controls (n&#x02009;=&#x02009;107)</th></tr></thead><tbody><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Anthropometric data</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Age range, y</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 6-7</td><td valign="top" align="left" rowspan="1" colspan="1">8/100 (8.0)</td><td valign="top" align="left" rowspan="1" colspan="1">17/107 (15.9)</td><td rowspan="6" valign="middle" align="left" colspan="1">.23</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 8-9</td><td valign="top" align="left" rowspan="1" colspan="1">9/100 (9.0)</td><td valign="top" align="left" rowspan="1" colspan="1">17/107 (15.9)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 10-11</td><td valign="top" align="left" rowspan="1" colspan="1">18/100 (18.0)</td><td valign="top" align="left" rowspan="1" colspan="1">18/107(16.8)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 12-13</td><td valign="top" align="left" rowspan="1" colspan="1">17/100 (17.0)</td><td valign="top" align="left" rowspan="1" colspan="1">18/107 (16.8)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 14-15</td><td valign="top" align="left" rowspan="1" colspan="1">24/100 (24.0)</td><td valign="top" align="left" rowspan="1" colspan="1">18/107 (16.8)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 16-17</td><td valign="top" align="left" rowspan="1" colspan="1">24/100 (24.0)</td><td valign="top" align="left" rowspan="1" colspan="1">19/107 (17.8)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Sex</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Girls</td><td valign="top" align="left" rowspan="1" colspan="1">48/100 (48.0)</td><td valign="top" align="left" rowspan="1" colspan="1">53/107 (49.5)</td><td rowspan="2" valign="middle" align="left" colspan="1">.83</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Boys</td><td valign="top" align="left" rowspan="1" colspan="1">52/100 (52.0)</td><td valign="top" align="left" rowspan="1" colspan="1">54/107 (50.5)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Weight, mean (SD), kg</td><td valign="top" align="left" rowspan="1" colspan="1">50.6 (18.3)</td><td valign="top" align="left" rowspan="1" colspan="1">44.7 (16.8)</td><td valign="top" align="left" rowspan="1" colspan="1">.02</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Height, mean (SD), cm</td><td valign="top" align="left" rowspan="1" colspan="1">156.1 (16.8)</td><td valign="top" align="left" rowspan="1" colspan="1">150.8 (18.2)</td><td valign="top" align="left" rowspan="1" colspan="1">.03</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> BMI, mean (SD)</td><td valign="top" align="left" rowspan="1" colspan="1">20.2 (4.6)</td><td valign="top" align="left" rowspan="1" colspan="1">18.9 (3.5)</td><td valign="top" align="left" rowspan="1" colspan="1">.05</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Clinical characteristics</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Resting heart rate, mean (SD), beats/min</td><td valign="top" align="left" rowspan="1" colspan="1">70.6 (15.9)</td><td valign="top" align="left" rowspan="1" colspan="1">77.9 (12.3)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Resting systolic blood pressure, mean (SD), mm Hg</td><td valign="top" align="left" rowspan="1" colspan="1">110.4 (14.4)</td><td valign="top" align="left" rowspan="1" colspan="1">109.3 (12.1)</td><td valign="top" align="left" rowspan="1" colspan="1">.88</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Resting diastolic blood pressure, mean (SD), mm Hg</td><td valign="top" align="left" rowspan="1" colspan="1">60.8 (11.1)</td><td valign="top" align="left" rowspan="1" colspan="1">60.6 (9.0)</td><td valign="top" align="left" rowspan="1" colspan="1">.56</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> NYHA functional class<xref rid="zoi241717t1n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> I</td><td valign="top" align="left" rowspan="1" colspan="1">83/90 (92.2)</td><td valign="top" align="left" rowspan="1" colspan="1">77/79 (97.5)</td><td rowspan="2" valign="middle" align="left" colspan="1">.18</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> II</td><td valign="top" align="left" rowspan="1" colspan="1">7/90 (7.8)</td><td valign="top" align="left" rowspan="1" colspan="1">2/79 (2.5)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Electrocardiography results</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> QRS, mean (SD), ms</td><td valign="top" align="left" rowspan="1" colspan="1">91.1 (17.5)</td><td valign="top" align="left" rowspan="1" colspan="1">85.2 (9.7)</td><td valign="top" align="left" rowspan="1" colspan="1">.02</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> QTc, mean (SD), ms</td><td valign="top" align="left" rowspan="1" colspan="1">436.5 (35.7)</td><td valign="top" align="left" rowspan="1" colspan="1">405.9 (28.0)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Echocardiography results</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Left ventricular ejection fraction, mean (SD), %</td><td valign="top" align="left" rowspan="1" colspan="1">66.5 (9.8)</td><td valign="top" align="left" rowspan="1" colspan="1">68.9 (5.7)</td><td valign="top" align="left" rowspan="1" colspan="1">.10</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Left ventricular diastolic diameter, mean (SD), mm</td><td valign="top" align="left" rowspan="1" colspan="1">43.7 (11.1)</td><td valign="top" align="left" rowspan="1" colspan="1">41.8 (8.7)</td><td valign="top" align="left" rowspan="1" colspan="1">.73</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Septal thickness, mean (SD), mm</td><td valign="top" align="left" rowspan="1" colspan="1">11.4 (12.9)</td><td valign="top" align="left" rowspan="1" colspan="1">7.6 (7.3)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Spirometry results</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> FEV<sub>1</sub>, mean (SD), <italic>z</italic> score</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.94 (1.19)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.25 (1.09)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> FVC, mean (SD), <italic>z</italic> score</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.05 (1.45)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.42 (1.13)</td><td valign="top" align="left" rowspan="1" colspan="1">.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> FEV<sub>1</sub> to FVC ratio, mean (SD), <italic>z</italic> score</td><td valign="top" align="left" rowspan="1" colspan="1">0.50 (2.81)</td><td valign="top" align="left" rowspan="1" colspan="1">0.36 (1.15)</td><td valign="top" align="left" rowspan="1" colspan="1">.64</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Sociodemographic data</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Patient&#x02019;s educational level</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Primary school</td><td valign="top" align="left" rowspan="1" colspan="1">29/99 (29.3)</td><td valign="top" align="left" rowspan="1" colspan="1">38/104 (36.5)</td><td rowspan="4" valign="middle" align="left" colspan="1">.55</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Middle school</td><td valign="top" align="left" rowspan="1" colspan="1">41/99 (41.4)</td><td valign="top" align="left" rowspan="1" colspan="1">40/104 (38.5)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> High school</td><td valign="top" align="left" rowspan="1" colspan="1">26/99 (26.3)</td><td valign="top" align="left" rowspan="1" colspan="1">25/104 (24.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Dropped out of school</td><td valign="top" align="left" rowspan="1" colspan="1">3/99 (3.0)</td><td valign="top" align="left" rowspan="1" colspan="1">1/104 (1.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Patient enrolled in special education<xref rid="zoi241717t1n2" ref-type="table-fn"><sup>b</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">6/92 (6.5)</td><td valign="top" align="left" rowspan="1" colspan="1">3/98 (3.1)</td><td valign="top" align="left" rowspan="1" colspan="1">.32</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Patient&#x02019;s grade progression</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Normal progression or skipped a grade</td><td valign="top" align="left" rowspan="1" colspan="1">92/98 (93.9)</td><td valign="top" align="left" rowspan="1" colspan="1">95/97 (97.9)</td><td rowspan="2" valign="middle" align="left" colspan="1">.28</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Repeated a grade</td><td valign="top" align="left" rowspan="1" colspan="1">6/98 (6.1)</td><td valign="top" align="left" rowspan="1" colspan="1">2/97 (2.1)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Patient&#x02019;s siblings, No.</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 0</td><td valign="top" align="left" rowspan="1" colspan="1">5/79 (6.3)</td><td valign="top" align="left" rowspan="1" colspan="1">1/78 (1.3)</td><td rowspan="3" valign="middle" align="left" colspan="1">.19</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 1-2</td><td valign="top" align="left" rowspan="1" colspan="1">50/79 (63.3)</td><td valign="top" align="left" rowspan="1" colspan="1">57/78 (73.1)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> &#x02265; 3</td><td valign="top" align="left" rowspan="1" colspan="1">24/79 (30.4)</td><td valign="top" align="left" rowspan="1" colspan="1">20/78 (25.6)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Mother&#x02019;s educational level</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Middle school diploma or no education</td><td valign="top" align="left" rowspan="1" colspan="1">30/98 (30.6)</td><td valign="top" align="left" rowspan="1" colspan="1">21/101 (20.8)</td><td rowspan="4" valign="middle" align="left" colspan="1">.26</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> High school diploma</td><td valign="top" align="left" rowspan="1" colspan="1">20/98 (20.4)</td><td valign="top" align="left" rowspan="1" colspan="1">17/101 (16.8)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Bachelor&#x02019;s degree or associate&#x02019;s degree</td><td valign="top" align="left" rowspan="1" colspan="1">25/98 (25.5)</td><td valign="top" align="left" rowspan="1" colspan="1">30/101 (29.7)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Master&#x02019;s degree or higher</td><td valign="top" align="left" rowspan="1" colspan="1">23/98 (23.5)</td><td valign="top" align="left" rowspan="1" colspan="1">33/101 (32.7)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Mother&#x02019;s professional situation</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Full time, part time, or retired</td><td valign="top" align="left" rowspan="1" colspan="1">72/98 (73.5)</td><td valign="top" align="left" rowspan="1" colspan="1">87/99 (87.9)</td><td rowspan="2" valign="middle" align="left" colspan="1">.009</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Temporary work, on sick leave, or unemployed</td><td valign="top" align="left" rowspan="1" colspan="1">26/98 (26.5)</td><td valign="top" align="left" rowspan="1" colspan="1">12/99 (12.1)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Mother&#x02019;s type of employment</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Farmer, shopkeeper, or business owner</td><td valign="top" align="left" rowspan="1" colspan="1">1/75 (1.3)</td><td valign="top" align="left" rowspan="1" colspan="1">9/85 (10.6)</td><td rowspan="3" valign="middle" align="left" colspan="1">.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Executive or higher intellectual profession or intermediate profession</td><td valign="top" align="left" rowspan="1" colspan="1">20/75 (26.7)</td><td valign="top" align="left" rowspan="1" colspan="1">41/85 (48.2)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Employee or worker</td><td valign="top" align="left" rowspan="1" colspan="1">54/75 (72.0)</td><td valign="top" align="left" rowspan="1" colspan="1">35/85 (41.2)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Father&#x02019;s educational level</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Middle school diploma or no education</td><td valign="top" align="left" rowspan="1" colspan="1">36/90 (40.0)</td><td valign="top" align="left" rowspan="1" colspan="1">29/97 (29.9)</td><td rowspan="4" valign="middle" align="left" colspan="1">.11</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> High school diploma</td><td valign="top" align="left" rowspan="1" colspan="1">21/90 (23.3)</td><td valign="top" align="left" rowspan="1" colspan="1">16/97 (16.5)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Bachelor&#x02019;s degree or associate&#x02019;s degree</td><td valign="top" align="left" rowspan="1" colspan="1">13/90 (14.4)</td><td valign="top" align="left" rowspan="1" colspan="1">25/97 (25.8)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Master&#x02019;s degree or higher</td><td valign="top" align="left" rowspan="1" colspan="1">20/90 (22.2)</td><td valign="top" align="left" rowspan="1" colspan="1">27/97 (27.8)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Father&#x02019;s professional situation</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Full time, part time, or retired</td><td valign="top" align="left" rowspan="1" colspan="1">84/91 (92.3)</td><td valign="top" align="left" rowspan="1" colspan="1">93/96 (96.9)</td><td rowspan="2" valign="middle" align="left" colspan="1">.20</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Temporary work, on sick leave, or unemployed</td><td valign="top" align="left" rowspan="1" colspan="1">7/91 (7.7)</td><td valign="top" align="left" rowspan="1" colspan="1">3/96 (3.1)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Father&#x02019;s type of employment</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Farmer, shopkeeper, or business owner</td><td valign="top" align="left" rowspan="1" colspan="1">14/82 (17.1)</td><td valign="top" align="left" rowspan="1" colspan="1">23/88 (26.1)</td><td rowspan="3" valign="middle" align="left" colspan="1">.04</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Executive or higher intellectual profession or intermediate profession</td><td valign="top" align="left" rowspan="1" colspan="1">23/82 (28.1)</td><td valign="top" align="left" rowspan="1" colspan="1">34/88 (38.6)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Employee or worker</td><td valign="top" align="left" rowspan="1" colspan="1">45/82 (54.9)</td><td valign="top" align="left" rowspan="1" colspan="1">31/88 (35.2)</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); FEV<sub>1</sub>, forced expiratory volume in the first second; FVC, forced vital capacity; NYHA, New York Heart Association; QTc, QT interval corrected by the Bazett formulae.</p><fn id="zoi241717t1n1"><label>
<sup>a</sup>
</label><p>None of the participants had an NYHA functional class higher than II.</p></fn><fn id="zoi241717t1n2"><label>
<sup>b</sup>
</label><p>Special education enrollment indicates participant enrolled in a special school to account for their particular educational status.</p></fn></table-wrap-foot></table-wrap><p>Among the 100 patients, 54 (54.0%) had inherited arrhythmia, and 46 (46.0%) had inherited cardiomyopathy (<xref rid="zoi241717t2" ref-type="table">Table 2</xref>). A genetic variation, extracted from medical records, was found in 77 of the 85 patients (90.6%) tested. &#x003b2;-Blockers were prescribed for 73 patients (73.0%) and flecainide for 3 patients (3.0%), and 10 patients (10.0%) had an implantable cardioverter-defibrillator.</p><table-wrap position="float" id="zoi241717t2"><label>Table 2. </label><caption><title>Characteristics of Children With Inherited Cardiac Disease</title></caption><table frame="hsides" rules="groups"><col width="57.36%" span="1"/><col width="42.64%" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Characteristic</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Participants, No./total No. (%) (n&#x02009;=&#x02009;100)</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Age at diagnosis, mean (SD), y</td><td valign="top" align="left" rowspan="1" colspan="1">7.5 (4.7)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Inherited arrhythmia</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Total</td><td valign="top" align="left" rowspan="1" colspan="1">54/100 (54.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Long QT syndrome</td><td valign="top" align="left" rowspan="1" colspan="1">47/54 (87.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Catecholaminergic polymorphic ventricular tachycardia</td><td valign="top" align="left" rowspan="1" colspan="1">7/54 (13.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Brugada syndrome</td><td valign="top" align="left" rowspan="1" colspan="1">0/54 (0)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Inherited cardiomyopathy</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Total</td><td valign="top" align="left" rowspan="1" colspan="1">46/100 (46.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Hypertrophic cardiomyopathy</td><td valign="top" align="left" rowspan="1" colspan="1">24/46 (52.2)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Dilated cardiomyopathy</td><td valign="top" align="left" rowspan="1" colspan="1">19/46 (41.3)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Arrhythmogenic right ventricular cardiomyopathy</td><td valign="top" align="left" rowspan="1" colspan="1">3/46 (6.5)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Genetic variants</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Total</td><td valign="top" align="left" rowspan="1" colspan="1">77/85 (90.6)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Inherited arrhythmia genetic variants</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">
<italic> KCNQ1</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">26/77 (33.8)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">
<italic> KCNH2</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">12/77 (15.6)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">
<italic> KCNJ2</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">3/77(3.9)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">
<italic> RYR2</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">5/77 (6.5)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">
<italic> PKP2</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">2/77 (2.6)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other</td><td valign="top" align="left" rowspan="1" colspan="1">2/77 (2.6)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Inherited cardiomyopathy genetic variants</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">
<italic> MYBPC3</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">7/77 (9.1)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">
<italic> MYH7</italic>
</td><td valign="top" align="left" rowspan="1" colspan="1">10/77 (12.9)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Other</td><td valign="top" align="left" rowspan="1" colspan="1">10/77 (12.9)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Cardiovascular events</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Cardiac arrest</td><td valign="top" align="left" rowspan="1" colspan="1">4/100 (4.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Ventricular tachycardia</td><td valign="top" align="left" rowspan="1" colspan="1">1/100 (1.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Supraventricular tachycardia</td><td valign="top" align="left" rowspan="1" colspan="1">3/100 (3.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Syncope</td><td valign="top" align="left" rowspan="1" colspan="1">5/100 (5.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Cardiac infections</td><td valign="top" align="left" rowspan="1" colspan="1">2/100 (2.0)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Comorbidity</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Respiratory disease</td><td valign="top" align="left" rowspan="1" colspan="1">5/100 (5.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Neurovascular disease</td><td valign="top" align="left" rowspan="1" colspan="1">4/100 (4.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Metabolic disease</td><td valign="top" align="left" rowspan="1" colspan="1">2/100 (2.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Urologic and digestive disease</td><td valign="top" align="left" rowspan="1" colspan="1">3/100 (3.0)</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Treatment</td><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Antiarrhythmic agents<xref rid="zoi241717t2n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">73/100 (73.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Heart failure treatment<xref rid="zoi241717t2n2" ref-type="table-fn"><sup>b</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">12/100 (12.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Noncardiac treatment</td><td valign="top" align="left" rowspan="1" colspan="1">10/100 (10.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Implantable cardioverter-defibrillator</td><td valign="top" align="left" rowspan="1" colspan="1">10/100 (10.0)</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Pacemaker</td><td valign="top" align="left" rowspan="1" colspan="1">1/100 (1.0)</td></tr></tbody></table><table-wrap-foot><fn id="zoi241717t2n1"><label>
<sup>a</sup>
</label><p>&#x003b2;-Blockers (nadolol, atenolol, bisoprolol, carvedilol, propranolol), calcium channel inhibitors, and flecainide antiarrhythmic.</p></fn><fn id="zoi241717t2n2"><label>
<sup>b</sup>
</label><p>Diuretics, angiotensin-converting enzyme inhibitors, aldosterone antagonists, and glifozin.</p></fn></table-wrap-foot></table-wrap></sec><sec id="H2-9-ZOI241717"><title>Results on Cardiopulmonary Fitness</title><p>The &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max was significantly lower in the group of children with inherited cardiac disease than in healthy controls, whether expressed as mean (SD) <italic>z</italic> score (&#x02212;1.49 [1.48] vs &#x02212;0.16 [0.97]; <italic>P</italic>&#x02009;&#x0003c;&#x02009;.001), mean (SD) raw values (32.2 [7.9] vs 40.2 [8.5] mL/kg/min; <italic>P</italic>&#x02009;&#x0003c;&#x02009;.001), or mean (SD) percentage-estimated values (78.5% [18.7%] vs 99.2% [18.6%]; <italic>P</italic>&#x02009;&#x0003c;&#x02009;.001) (<xref rid="zoi241717t3" ref-type="table">Table 3</xref>). Similar results were observed after adjusting for &#x003b2;-blocker treatment and BMI, with an adjusted absolute &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max <italic>z</italic> score difference of &#x02212;0.69 (95% CI, &#x02013;1.21 to &#x02013;0.18), representing a raw difference of &#x02013;4.0 mL/kg/min (95% CI, &#x02013;7.0 to &#x02013;1.0 mL/kg/min). No significant difference was observed for <italic>z</italic> scores for &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max and VAT between disease subgroups (eTable in <xref rid="note-ZOI241717-1-s" ref-type="supplementary-material">Supplement 1</xref>). The VAT was lower in children with inherited cardiac disease, even after adjusting for &#x003b2;-blocker treatment and BMI.</p><table-wrap position="float" id="zoi241717t3"><label>Table 3. </label><caption><title>Cardiopulmonary Fitness Among Children With Inherited Cardiac Disease vs Healthy Controls</title></caption><table frame="hsides" rules="groups"><col width="18.7%" span="1"/><col width="13.52%" span="1"/><col width="10.56%" span="1"/><col width="16.93%" span="1"/><col width="7.84%" span="1"/><col width="21.88%" span="1"/><col width="10.57%" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">CPET parameters</th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Mean (SD)</th><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Absolute difference (95% CI)</th><th rowspan="2" valign="top" align="left" scope="col" colspan="1"><italic>P</italic> value</th><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Adjusted absolute difference (95% CI)<xref rid="zoi241717t3n1" ref-type="table-fn"><sup>a</sup></xref></th><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Adjusted <italic>P</italic> value<xref rid="zoi241717t3n1" ref-type="table-fn"><sup>a</sup></xref></th></tr><tr><th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Patients (n&#x02009;=&#x02009;100)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Controls (n&#x02009;=&#x02009;107)</th></tr></thead><tbody><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1">
<bold>Maximal CPET parameters</bold>
</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">&#x00056;&#x00307;<sc>o</sc><sub>2</sub>max</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">
<italic>z</italic> Score</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.49 (1.48)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.16 (0.97)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.33 (&#x02212;1.68 to &#x02212;0.99)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.69 (&#x02212;1.21 to &#x02212;0.18)</td><td valign="top" align="left" rowspan="1" colspan="1">.008</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Raw value, mL/kg/min</td><td valign="top" align="left" rowspan="1" colspan="1">32.2 (7.9)</td><td valign="top" align="left" rowspan="1" colspan="1">40.2 (8.5)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;8.0 (&#x02212;10.2 to &#x02212;5.7)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;4.0 (&#x02212;7.0 to &#x02212;1.0)</td><td valign="top" align="left" rowspan="1" colspan="1">.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Percentage-estimated value, %</td><td valign="top" align="left" rowspan="1" colspan="1">78.5 (18.7)</td><td valign="top" align="left" rowspan="1" colspan="1">99.2 (18.6)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;20.7 (&#x02212;25.8 to &#x02212;15.6)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;8.4 (&#x02212;14.7 to &#x02212;2.1)</td><td valign="top" align="left" rowspan="1" colspan="1">.009</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Impaired &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max, No./total No. (%)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">
<italic>z</italic> Score &#x0003c;&#x02212;1.64</td><td valign="top" align="left" rowspan="1" colspan="1">40/100 (40.0)</td><td valign="top" align="left" rowspan="1" colspan="1">7/107 (6.5)</td><td valign="top" align="left" rowspan="1" colspan="1">33.5 (22.8 to 44.1)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA </td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Percentage-estimated value &#x0003c;80%</td><td valign="top" align="left" rowspan="1" colspan="1">49/100 (49.0)</td><td valign="top" align="left" rowspan="1" colspan="1">14/107 (13.1)</td><td valign="top" align="left" rowspan="1" colspan="1">35.9 (24.2 to 47.6)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">NA </td><td valign="top" align="left" rowspan="1" colspan="1">NA </td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Workload</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">
<italic>z</italic> Score</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.40 (1.56)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.10 (1.12)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.30 (&#x02212;1.67 to &#x02212;0.92)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.55 (&#x02212;1.10 to 0.01)</td><td valign="top" align="left" rowspan="1" colspan="1">.05</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Raw value, W</td><td valign="top" align="left" rowspan="1" colspan="1">116.8 (49.4)</td><td valign="top" align="left" rowspan="1" colspan="1">134.2 (60.3)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;17.3 (&#x02212;32.4 to &#x02212;2.2)</td><td valign="top" align="left" rowspan="1" colspan="1">.06</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;5.6 (&#x02212;26.8 to 15.6)</td><td valign="top" align="left" rowspan="1" colspan="1">.60</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Heart rate</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">
<italic>z</italic> Score</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;4.00 (3.04)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.21 (1.75)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;3.79 (&#x02212;4.48 to &#x02212;3.10)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.69 (&#x02212;1.57 to 0.20)</td><td valign="top" align="left" rowspan="1" colspan="1">.13</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Raw value, beats/min</td><td valign="top" align="left" rowspan="1" colspan="1">152.5 (27.1)</td><td valign="top" align="left" rowspan="1" colspan="1">186.2 (15.5)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;33.7 (&#x02212;39.8 to &#x02212;27.6)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;6.5 (&#x02212;14.4 to 1.4)</td><td valign="top" align="left" rowspan="1" colspan="1">.11</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Oxygen pulse</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">
<italic>z</italic> Score</td><td valign="top" align="left" rowspan="1" colspan="1">0.05 (1.41)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.09 (1.10)</td><td valign="top" align="left" rowspan="1" colspan="1">0.14 (&#x02212;0.21 to 0.49)</td><td valign="top" align="left" rowspan="1" colspan="1">.22</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.46 (&#x02212;0.99 to 0.07)</td><td valign="top" align="left" rowspan="1" colspan="1">.09</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Raw value, mL/beat</td><td valign="top" align="left" rowspan="1" colspan="1">10.4 (3.6)</td><td valign="top" align="left" rowspan="1" colspan="1">9.3 (3.2)</td><td valign="top" align="left" rowspan="1" colspan="1">1.1 (0.1 to 2.0)</td><td valign="top" align="left" rowspan="1" colspan="1">.03</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.3 (&#x02212;1.6 to 1.0)</td><td valign="top" align="left" rowspan="1" colspan="1">.66</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Respiratory exchange rate</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">
<italic>z</italic> Score</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.53 (1.20)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.19 (1.04)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.34 (&#x02212;0.65 to &#x02212;0.04)</td><td valign="top" align="left" rowspan="1" colspan="1">.007</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.21 (&#x02212;0.69 to 0.27)</td><td valign="top" align="left" rowspan="1" colspan="1">.39</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Raw value, ratio</td><td valign="top" align="left" rowspan="1" colspan="1">1.12 (0.11)</td><td valign="top" align="left" rowspan="1" colspan="1">1.15 (0.10)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.02 (&#x02212;0.05 to 0.01)</td><td valign="top" align="left" rowspan="1" colspan="1">.08</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.01 (&#x02212;0.06 to 0.03)</td><td valign="top" align="left" rowspan="1" colspan="1">.54</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Ventilatory efficiency</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">
<italic>z</italic> Score</td><td valign="top" align="left" rowspan="1" colspan="1">0.48 (1.17)</td><td valign="top" align="left" rowspan="1" colspan="1">0.51 (1.16)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.02 (&#x02212;0.36 to 0.32)</td><td valign="top" align="left" rowspan="1" colspan="1">.71</td><td valign="top" align="left" rowspan="1" colspan="1">0.02 (&#x02212;0.49 to 0.53)</td><td valign="top" align="left" rowspan="1" colspan="1">.94</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Raw value, ratio</td><td valign="top" align="left" rowspan="1" colspan="1">32.2 (5.1)</td><td valign="top" align="left" rowspan="1" colspan="1">32.8 (5.3)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.6 (&#x02212;2.1 to 0.9)</td><td valign="top" align="left" rowspan="1" colspan="1">.44</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.6 (&#x02212;2.9 to 1.6)</td><td valign="top" align="left" rowspan="1" colspan="1">.58</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Breathing reserve</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">
<italic>z</italic> Score</td><td valign="top" align="left" rowspan="1" colspan="1">0.38 (1.19)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.11 (0.99)</td><td valign="top" align="left" rowspan="1" colspan="1">0.49 (0.17 to 0.82)</td><td valign="top" align="left" rowspan="1" colspan="1">.001</td><td valign="top" align="left" rowspan="1" colspan="1">0.22 (&#x02212;0.26 to 0.70)</td><td valign="top" align="left" rowspan="1" colspan="1">.36</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Raw value, %</td><td valign="top" align="left" rowspan="1" colspan="1">31.9 (17.5)</td><td valign="top" align="left" rowspan="1" colspan="1">24.8 (14.2)</td><td valign="top" align="left" rowspan="1" colspan="1">7.2 (2.4 to 11.9)</td><td valign="top" align="left" rowspan="1" colspan="1">.001</td><td valign="top" align="left" rowspan="1" colspan="1">3.3 (&#x02212;3.7 to 10.3)</td><td valign="top" align="left" rowspan="1" colspan="1">.36</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Tidal volume</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">
<italic>z</italic> Score</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.24 (2.59)</td><td valign="top" align="left" rowspan="1" colspan="1">0.09 (1.15)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.33 (&#x02212;1.89 to &#x02212;0.76)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.48 (&#x02212;1.32 to 0.35)</td><td valign="top" align="left" rowspan="1" colspan="1">.26</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Raw value, mL</td><td valign="top" align="left" rowspan="1" colspan="1">1249.8 (576.8)</td><td valign="top" align="left" rowspan="1" colspan="1">1364.5 (555.5)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;114.7 (&#x02212;271.5 to 42.1)</td><td valign="top" align="left" rowspan="1" colspan="1">.13</td><td valign="top" align="left" rowspan="1" colspan="1">6.9 (&#x02212;211.8 to 225.6)</td><td valign="top" align="left" rowspan="1" colspan="1">.95</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Systolic blood pressure</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Raw value, mm Hg</td><td valign="top" align="left" rowspan="1" colspan="1">138 (27)</td><td valign="top" align="left" rowspan="1" colspan="1">140 (25)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;2.5 (&#x02212;9.8 to 4.8)</td><td valign="top" align="left" rowspan="1" colspan="1">.45</td><td valign="top" align="left" rowspan="1" colspan="1">1.0 (&#x02212;9.5 to 11.5)</td><td valign="top" align="left" rowspan="1" colspan="1">.86</td></tr><tr><td colspan="7" valign="top" align="left" scope="col" rowspan="1">
<bold>CPET parameters at VAT</bold>
</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">VAT</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">
<italic>z</italic> Score</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.28 (1.51)</td><td valign="top" align="left" rowspan="1" colspan="1">0.03 (0.99)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.31 (&#x02212;1.67 to &#x02212;0.95)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.57 (&#x02212;1.10 to &#x02212;0.04)</td><td valign="top" align="left" rowspan="1" colspan="1">.03</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Raw value, mL/kg/min</td><td valign="top" align="left" rowspan="1" colspan="1">22.4 (7.1)</td><td valign="top" align="left" rowspan="1" colspan="1">29.0 (7.4)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;6.6 (&#x02212;8.6 to &#x02212;4.6)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;2.7 (&#x02212;5.4 to 0.0)</td><td valign="top" align="left" rowspan="1" colspan="1">.05</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Percentage-estimated VAT, %</td><td valign="top" align="left" rowspan="1" colspan="1">54.6 (17.5)</td><td valign="top" align="left" rowspan="1" colspan="1">71.5 (16.8)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;16.9 (&#x02212;21.6 to &#x02212;12.2)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;5.3 (&#x02212;11.3 to 0.7)</td><td valign="top" align="left" rowspan="1" colspan="1">.08</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Impaired VAT, No./total No. (%)</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">
<italic>z</italic> Score &#x0003c;&#x02212;1.64</td><td valign="top" align="left" rowspan="1" colspan="1">31/97 (32.0)</td><td valign="top" align="left" rowspan="1" colspan="1">7/107 (6.5)</td><td valign="top" align="left" rowspan="1" colspan="1">25.4 (15.0 to 35.8)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Percentage-estimated value &#x0003c;55%</td><td valign="top" align="left" rowspan="1" colspan="1">46/97 (47.4)</td><td valign="top" align="left" rowspan="1" colspan="1">18/107 (16.8)</td><td valign="top" align="left" rowspan="1" colspan="1">30.6 (18.4 to 42.8)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Workload</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Raw value, W</td><td valign="top" align="left" rowspan="1" colspan="1">70.7 (33.5)</td><td valign="top" align="left" rowspan="1" colspan="1">86.6 (42.0)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;15.9 (&#x02212;26.4 to &#x02212;5.4)</td><td valign="top" align="left" rowspan="1" colspan="1">.005</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;8.5 (&#x02212;24.3 to 7.3)</td><td valign="top" align="left" rowspan="1" colspan="1">.29</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Heart rate</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Raw value, beats/min</td><td valign="top" align="left" rowspan="1" colspan="1">123.4 (24.0)</td><td valign="top" align="left" rowspan="1" colspan="1">156.5 (15.1)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;33.1 (&#x02212;38.7 to &#x02212;27.4)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;9.0 (&#x02212;16.5 to &#x02212;1.5)</td><td valign="top" align="left" rowspan="1" colspan="1">.02</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Oxygen pulse</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Raw value, mL/beat</td><td valign="top" align="left" rowspan="1" colspan="1">8.7 (2.9)</td><td valign="top" align="left" rowspan="1" colspan="1">7.9 (2.7)</td><td valign="top" align="left" rowspan="1" colspan="1">0.7 (0.0 to 1.5)</td><td valign="top" align="left" rowspan="1" colspan="1">.03</td><td valign="top" align="left" rowspan="1" colspan="1">0.01 (&#x02212;1.1 to 1.1)</td><td valign="top" align="left" rowspan="1" colspan="1">.99</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: BMI, body mass index; CPET, cardiopulmonary exercise test; NA, not applicable; VAT, ventilatory anaerobic threshold; &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max, maximal oxygen uptake.</p><fn id="zoi241717t3n1"><label>
<sup>a</sup>
</label><p>Adjusted for &#x003b2;-blocker treatment and BMI for all parameters (except for <italic>z</italic> scores with adjustment for &#x003b2;-blocker treatment only).</p></fn></table-wrap-foot></table-wrap><p>Overall, group differences in cardiopulmonary fitness were identified more frequently using the <italic>z</italic> score model than using the linear equations of Cooper et al.<sup><xref rid="zoi241717r34" ref-type="bibr">34</xref></sup> In addition, in both groups, fewer children were considered to have poor cardiopulmonary fitness using the <italic>z</italic> score model than the linear equations of Cooper et al.<sup><xref rid="zoi241717r34" ref-type="bibr">34</xref></sup> Among the 100 patients and 107 controls, impaired &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max was observed in 40 patients (40.0%) and 7 healthy children (6.5%) using the <italic>z</italic> score model compared with 49 patients (49.0%) and 14 controls (13.1%) using the equations of Cooper et al<sup><xref rid="zoi241717r34" ref-type="bibr">34</xref></sup> (both <italic>P</italic>&#x02009;<italic>&#x0003c;</italic>&#x02009;.001) (<xref rid="zoi241717t3" ref-type="table">Table 3</xref>). Similar findings were observed using the VAT threshold: 31 of 97 patients (32.0%) vs 7 of 107 controls (6.5%) had impaired VAT with the <italic>z</italic> score model, and 46 of 97 patients (47.4%) vs 18 of 107 controls (16.8%) had impaired VAT with the linear equations of Cooper et al<sup><xref rid="zoi241717r34" ref-type="bibr">34</xref></sup> (all <italic>P</italic>&#x02009;<italic>&#x0003c;</italic>&#x02009;.001). All CPET parameter comparisons are presented in <xref rid="zoi241717t3" ref-type="table">Table 3</xref>.</p></sec><sec id="H2-10-ZOI241717"><title>Physical Activity Results</title><p>The mean (SD) valid wear time for accelerometry was appropriate in both the patient group (10.6 [3.3] days and 13.4 [1.7] h/d) and the control group (9.5 [2.9] days and 12.9 [1.2] h/d). Seven patients and 9 controls were excluded from the analysis due to insufficient valid data (&#x02265;3 days with 10 h/d). Children with inherited cardiac disease engaged in significantly less vigorous and moderate to vigorous physical activity (vigorous: mean [SD], 12.0 [10.5] vs 16.1 [12.0] min/d; <italic>P</italic>&#x02009;=&#x02009;.005; moderate to vigorous: mean [SD], 42.0 [23.6] vs 48.2 [20.4] min/d; <italic>P</italic>&#x02009;=&#x02009;.009) and more sedentary time (mean [SD], 568.6 [122.5] vs 524.3 [101.4] min/d; <italic>P</italic>&#x02009;=&#x02009;.02) than healthy controls (<xref rid="zoi241717t4" ref-type="table">Table 4</xref>). No significant differences were found for light and moderate intensity.<sup><xref rid="zoi241717r45" ref-type="bibr">45</xref></sup> On questionnaires, patients had lower scores of physical activity and intrinsic motivation than controls.</p><table-wrap position="float" id="zoi241717t4"><label>Table 4. </label><caption><title>Physical Activity Among Children With Inherited Cardiac Disease vs Healthy Controls</title></caption><table frame="hsides" rules="groups"><col width="35.63%" span="1"/><col width="15.51%" span="1"/><col width="16.22%" span="1"/><col width="23.31%" span="1"/><col width="9.33%" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Physical activity measurement</th><th colspan="2" valign="top" align="left" scope="colgroup" rowspan="1">Mean (SD)</th><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Absolute difference (95% CI)</th><th rowspan="2" valign="top" align="left" scope="col" colspan="1"><italic>P</italic> value</th></tr><tr><th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Patients (n&#x02009;=&#x02009;93)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Controls (n&#x02009;=&#x02009;98)</th></tr></thead><tbody><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Accelerometry-derived physical activity</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Sedentary time, min/d</td><td valign="top" align="left" rowspan="1" colspan="1">568.6 (122.5)</td><td valign="top" align="left" rowspan="1" colspan="1">524.3 (101.4)</td><td valign="top" align="left" rowspan="1" colspan="1">44.3 (12.3 to 76.4)</td><td valign="top" align="left" rowspan="1" colspan="1">.02</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Light intensity, min/d</td><td valign="top" align="left" rowspan="1" colspan="1">203.4 (62.9)</td><td valign="top" align="left" rowspan="1" colspan="1">215.3 (61.3)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;12.0 (&#x02212;29.7 to 5.8)</td><td valign="top" align="left" rowspan="1" colspan="1">.12</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Moderate intensity, min/d</td><td valign="top" align="left" rowspan="1" colspan="1">29.9 (15.2)</td><td valign="top" align="left" rowspan="1" colspan="1">31.92 (12.7)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;2.0 (&#x02212;6.0 to 2.0)</td><td valign="top" align="left" rowspan="1" colspan="1">.09</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Vigorous intensity, min/d</td><td valign="top" align="left" rowspan="1" colspan="1">12.0 (10.5)</td><td valign="top" align="left" rowspan="1" colspan="1">16.1 (12.0)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;4.1 (&#x02212;7.3 to &#x02212;0.9)</td><td valign="top" align="left" rowspan="1" colspan="1">.005</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> MVPA, min/d</td><td valign="top" align="left" rowspan="1" colspan="1">42.0 (23.6)</td><td valign="top" align="left" rowspan="1" colspan="1">48.2 (20.4)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;6.1 (&#x02212;12.4 to 0.2)</td><td valign="top" align="left" rowspan="1" colspan="1">.009</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Steps/d</td><td valign="top" align="left" rowspan="1" colspan="1">7662.3 (2991.3)</td><td valign="top" align="left" rowspan="1" colspan="1">8366.8 (2315.4)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;704.5 (1471.3 to 62.3)</td><td valign="top" align="left" rowspan="1" colspan="1">.02</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Meeting WHO guidelines, No./total No. (%)<xref rid="zoi241717t4n1" ref-type="table-fn"><sup>a</sup></xref><sup>,</sup><xref rid="zoi241717t4n2" ref-type="table-fn"><sup>b</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">14/81 (17.3)</td><td valign="top" align="left" rowspan="1" colspan="1">20/87 (23.0)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;5.7 (&#x02212;17.8 to 6.4)</td><td valign="top" align="left" rowspan="1" colspan="1">.36</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Physical activity questionnaire (total score)</td><td valign="top" align="left" rowspan="1" colspan="1">24.9 (0.3)</td><td valign="top" align="left" rowspan="1" colspan="1">26.9 (4.2)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;2.0 (&#x02212;3.4 to &#x02212;0.6)</td><td valign="top" align="left" rowspan="1" colspan="1">.008</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Motivation toward health-oriented physical activity</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Intrinsic motivation</td><td valign="top" align="left" rowspan="1" colspan="1">5.2 (1.6)</td><td valign="top" align="left" rowspan="1" colspan="1">5.7 (1.2)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.6 (&#x02212;1.0 to &#x02212;0.2)</td><td valign="top" align="left" rowspan="1" colspan="1">.01</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Extrinsic motivation</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Integrated regulation</td><td valign="top" align="left" rowspan="1" colspan="1">4.2 (1.9)</td><td valign="top" align="left" rowspan="1" colspan="1">5.1 (1.6)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.8 (&#x02212;1.3 to &#x02212;0.3)</td><td valign="top" align="left" rowspan="1" colspan="1">.002</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Identified regulation</td><td valign="top" align="left" rowspan="1" colspan="1">5.3 (1.5)</td><td valign="top" align="left" rowspan="1" colspan="1">5.8 (1.2)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.5 (&#x02212;0.9 to &#x02212;0.1)</td><td valign="top" align="left" rowspan="1" colspan="1">.03</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Introjected regulation</td><td valign="top" align="left" rowspan="1" colspan="1">3.8 (1.6)</td><td valign="top" align="left" rowspan="1" colspan="1">4.4 (1.6)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.7 (&#x02212;1.1 to &#x02212;0.2)</td><td valign="top" align="left" rowspan="1" colspan="1">.007</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> External regulation</td><td valign="top" align="left" rowspan="1" colspan="1">1.6 (1.1)</td><td valign="top" align="left" rowspan="1" colspan="1">1.7 (1.2)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.1 (&#x02212;0.4 to 0.2)</td><td valign="top" align="left" rowspan="1" colspan="1">.52</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Amotivation</td><td valign="top" align="left" rowspan="1" colspan="1">1.6 (1.0)</td><td valign="top" align="left" rowspan="1" colspan="1">1.4 (0.8)</td><td valign="top" align="left" rowspan="1" colspan="1">0.2 (0.0 to 0.5)</td><td valign="top" align="left" rowspan="1" colspan="1">.13</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: MVPA, moderate to vigorous physical activity; WHO, World Health Organization.</p><fn id="zoi241717t4n1"><label>
<sup>a</sup>
</label><p>WHO activity guidelines for children aged between 5 and 17 years are at least 60 minutes per day of moderate to vigorous intensity.<sup><xref rid="zoi241717r45" ref-type="bibr">45</xref></sup></p></fn><fn id="zoi241717t4n2"><label>
<sup>b</sup>
</label><p>Compliance with international guidelines (&#x02265;60 minutes of MVPA/d) was evaluated only for children and adolescents with at least 6 valid days.</p></fn></table-wrap-foot></table-wrap></sec><sec id="H2-11-ZOI241717"><title>Factors Associated With Maximum Oxygen Uptake <italic>z</italic> Score Among Children and Adolescents With Inherited Cardiac Disease</title><p>Among children with inherited cardiac disease, the &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max <italic>z</italic> score was associated with clinical, functional, sociodemographic, and behavioral parameters in univariate analysis (<xref rid="zoi241717t5" ref-type="table">Table 5</xref>). The amounts of daily moderate to vigorous physical activity and daily vigorous physical activity assessed by accelerometers were lower for patients with inherited heart disease but were not associated with &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max in the multivariable model (univariate <italic>r</italic>&#x02009;&#x02264;&#x02009;0.30). In multivariable analysis, the factors associated with a higher &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max <italic>z</italic> score were the absence of an implantable cardioverter-defibrillator, lower NYHA functional class, greater QRS duration, lower left ventricular diastolic diameter, higher forced vital capacity, higher VAT, male sex, normal progression of schooling, having no siblings, higher educational level for mother, lower educational level for father, higher score on the physical activity questionnaire, and lower extrinsic motivation regulated externally. The final multivariable model explained 80% of the &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max <italic>z</italic> score.</p><table-wrap position="float" id="zoi241717t5"><label>Table 5. </label><caption><title>Factors Associated With Maximum Oxygen Uptake <italic>z</italic> Score Among Children With Inherited Cardiac Disease</title></caption><table frame="hsides" rules="groups"><col width="27.23%" span="1"/><col width="15.1%" span="1"/><col width="12.32%" span="1"/><col width="7.92%" span="1"/><col width="19.66%" span="1"/><col width="9.68%" span="1"/><col width="7.96%" span="1"/><col width="0.13%" span="1"/><thead><tr><th rowspan="2" valign="top" align="left" scope="col" colspan="1">Parameter</th><th colspan="3" valign="top" align="left" scope="colgroup" rowspan="1">Univariate analysis</th><th colspan="4" valign="top" align="left" scope="colgroup" rowspan="1">Multivariable analysis (n&#x02009;=&#x02009;100)</th></tr><tr><th valign="top" colspan="1" align="left" scope="colgroup" rowspan="1">Correlation coefficient <italic>r</italic> or mean (SD) value</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Raw &#x003b2; (95% CI)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic>P</italic> value</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Adjusted &#x003b2; (95% CI)</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Standardized &#x003b2;</th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"><italic>P</italic> value</th></tr></thead><tbody><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Clinical parameters</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Resting systolic blood pressure, mm H<italic>g</italic><xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>&#x02009;=&#x02009;0.15</td><td valign="top" align="left" rowspan="1" colspan="1">0.02 (&#x02212;0.01 to 0.04)</td><td valign="top" align="left" rowspan="1" colspan="1">.15</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Mean QRS, ms<xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>&#x02009;=&#x02009;0.14</td><td valign="top" align="left" rowspan="1" colspan="1">0.02 (0.00 to 0.04)</td><td valign="top" align="left" rowspan="1" colspan="1">.08</td><td valign="top" align="left" rowspan="1" colspan="1">0.02 (0.01 to 0.03)</td><td valign="top" align="left" rowspan="1" colspan="1">0.22</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Left ventricular diastolic diameter, mm<xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>&#x02009;=&#x02009;0.27</td><td valign="top" align="left" rowspan="1" colspan="1">0.03 (0.00 to 0.05)</td><td valign="top" align="left" rowspan="1" colspan="1">.04</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.02 (&#x02212;0.03 to &#x02212;0.01)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.17</td><td valign="top" align="left" rowspan="1" colspan="1">.01</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Type of disease</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Inherited arrhythmia</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.60 (1.43)</td><td valign="top" align="left" rowspan="1" colspan="1">0.25 (&#x02212;0.34 to 0.84)</td><td valign="top" align="left" rowspan="1" colspan="1">.41</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Inherited cardiomyopathy</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.35 (1.56)</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">NYHA functional class<xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref><sup>,</sup><xref rid="zoi241717t5n2" ref-type="table-fn"><sup>b</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> I</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.35 (1.33)</td><td valign="top" align="left" rowspan="1" colspan="1">2.15 (1.05 to 3.25)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">0.79 (0.20 to 1.38)</td><td valign="top" align="left" rowspan="1" colspan="1">0.15</td><td valign="top" align="left" rowspan="1" colspan="1">.009</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> II</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;3.50 (2.17)</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">&#x003b2;-Blockers<xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> No</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.85 (1.46)</td><td valign="top" align="left" rowspan="1" colspan="1">0.88 (0.23 to 1.52)</td><td valign="top" align="left" rowspan="1" colspan="1">.01</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Yes</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.73 (1.43)</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Implantable cardioverter-defibrillator<xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> No</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.36 (1.43)</td><td valign="top" align="left" rowspan="1" colspan="1">1.26 (0.31 to 2.21)</td><td valign="top" align="left" rowspan="1" colspan="1">.01</td><td valign="top" align="left" rowspan="1" colspan="1">0.78 (0.24 to 1.31)</td><td valign="top" align="left" rowspan="1" colspan="1">0.16</td><td valign="top" align="left" rowspan="1" colspan="1">.005</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Yes</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;2.62 (1.53)</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Functional parameters</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> FEV<sub>1</sub>
<italic>z</italic> score<xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>&#x02009;=&#x02009;0.36</td><td valign="top" align="left" rowspan="1" colspan="1">0.45 (0.20 to 0.71)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> FVC <italic>z</italic> score<xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>&#x02009;=&#x02009;0.39</td><td valign="top" align="left" rowspan="1" colspan="1">0.41 (0.20 to 0.61)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">0.23 (0.13 to 0.33)</td><td valign="top" align="left" rowspan="1" colspan="1">0.25</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> VAT <italic>z</italic> score<xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>&#x02009;=&#x02009;0.74</td><td valign="top" align="left" rowspan="1" colspan="1">0.72 (0.59 to 0.85)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">0.58 (0.47 to 0.68)</td><td valign="top" align="left" rowspan="1" colspan="1">0.62</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Sociodemographic parameters</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1"> Sex<xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Boys</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.24 (1.34)</td><td valign="top" align="left" rowspan="1" colspan="1">0.53 (&#x02212;0.06 to 1.11)</td><td valign="top" align="left" rowspan="1" colspan="1">.08</td><td valign="top" align="left" rowspan="1" colspan="1">0.43 (0.12 to 0.74)</td><td valign="top" align="left" rowspan="1" colspan="1">0.15</td><td valign="top" align="left" rowspan="1" colspan="1">.006</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Girls</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.76 (1.59)</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Patient&#x02019;s grade progression<xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Normal progression or skipped a grade</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.42 (1.48)</td><td valign="top" align="left" rowspan="1" colspan="1">0.93 (&#x02212;0.30 to 2.17)</td><td valign="top" align="left" rowspan="1" colspan="1">.14</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Repeated a grade</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;2.35 (1.43)</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Patient&#x02019;s special education<xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref><sup>,</sup><xref rid="zoi241717t5n3" ref-type="table-fn"><sup>c</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> No</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.38 (1.38)</td><td valign="top" align="left" rowspan="1" colspan="1">1.66 (0.44 to 2.87)</td><td valign="top" align="left" rowspan="1" colspan="1">.01</td><td valign="top" align="left" rowspan="1" colspan="1">0.58 (0.00 to 1.17)</td><td valign="top" align="left" rowspan="1" colspan="1">0.11</td><td valign="top" align="left" rowspan="1" colspan="1">.05</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Yes</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;3.04 (2.34)</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Mother&#x02019;s educational level<xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Master&#x02019;s degree or higher</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.89 (1.23)</td><td valign="top" align="left" rowspan="1" colspan="1">0.85 (0.12 to 1.59)</td><td valign="top" align="left" rowspan="1" colspan="1">.07</td><td valign="top" align="left" rowspan="1" colspan="1">0.53 (0.11 to 0.96)</td><td valign="top" align="left" rowspan="1" colspan="1">0.15</td><td valign="top" align="left" rowspan="1" colspan="1">.05</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Bachelor&#x02019;s degree</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.57 (1.31)</td><td valign="top" align="left" rowspan="1" colspan="1">0.17 (&#x02212;0.55 to 0.88)</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">0.05 (&#x02212;0.33 to 0.44)</td><td valign="top" align="left" rowspan="1" colspan="1">0.02</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Middle school, high school diploma, or no education</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.74 (1.63)</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Mother&#x02019;s professional situation<xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Full time, part time, or retired</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.35 (1.60)</td><td valign="top" align="left" rowspan="1" colspan="1">0.46 (&#x02212;0.21 to 1.14)</td><td valign="top" align="left" rowspan="1" colspan="1">.17</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Temporary work, on sick leave, or unemployed</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.82 (1.10)</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Mother&#x02019;s type of employment<xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Farmer, shopkeeper, or business owner</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.66 (0.00)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.02 (&#x02212;3.11 to 3.08)</td><td valign="top" align="left" rowspan="1" colspan="1">.06</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Executive or higher intellectual profession or intermediate profession</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.67 (1.27)</td><td valign="top" align="left" rowspan="1" colspan="1">0.97 (0.17 to 1.77)</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Employee or worker</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.64 (1.63)</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Father&#x02019;s educational level<xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Master&#x02019;s degree or higher</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.91 (1.26)</td><td valign="top" align="left" rowspan="1" colspan="1">0.58 (&#x02212;0.18 to 1.34)</td><td valign="top" align="left" rowspan="1" colspan="1">.15</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.34 (&#x02212;0.77 to 0.09)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.10</td><td valign="top" align="left" rowspan="1" colspan="1">0.01</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Bachelor&#x02019;s degree</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.90 (0.99)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.40 (&#x02212;1.30 to 0.50)</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.73 (&#x02212;1.21 to &#x02212;0.26)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.18</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Middle school, high school diploma, or no education</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.50 (1.62)</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">No. of patient&#x02019;s siblings<xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> &#x02265;3</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;2.49 (1.40)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.31 (&#x02212;2.75 to 0.13)</td><td valign="top" align="left" rowspan="1" colspan="1">.01</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.86 (&#x02212;1.39 to &#x02212;0.34)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.26</td><td valign="top" align="left" rowspan="1" colspan="1">.005</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 1-2</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.35 (1.49)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.17 (&#x02212;1.54 to 1.20)</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.69 (&#x02212;1.16 to &#x02212;0.22)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.23</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> 0</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.18 (1.60)</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Behavioral parameters</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Physical activity questionnaire total score<xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>&#x02009;=&#x02009;0.36</td><td valign="top" align="left" rowspan="1" colspan="1">0.08 (0.03 to 0.13)</td><td valign="top" align="left" rowspan="1" colspan="1">.003</td><td valign="top" align="left" rowspan="1" colspan="1">0.03 (0.01 to 0.06)</td><td valign="top" align="left" rowspan="1" colspan="1">0.14</td><td valign="top" align="left" rowspan="1" colspan="1">.009</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Intrinsic motivation<xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>&#x02009;=&#x02009;0.43</td><td valign="top" align="left" rowspan="1" colspan="1">0.44 (0.28 to 0.61)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Extrinsic motivation</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Identified regulation<xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>&#x02009;=&#x02009;0.34</td><td valign="top" align="left" rowspan="1" colspan="1">0.38 (0.20 to 0.56)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x0003c;.001</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Introjected regulation<xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>&#x02009;=&#x02009;0.12</td><td valign="top" align="left" rowspan="1" colspan="1">0.16 (&#x02212;0.02 to 0.34)</td><td valign="top" align="left" rowspan="1" colspan="1">.09</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> External regulation<xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>&#x02009;=&#x02009;&#x02212;0.21</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.22 (&#x02212;0.50 to 0.06)</td><td valign="top" align="left" rowspan="1" colspan="1">.13</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.24 (&#x02212;0.37 to &#x02212;0.10)</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.17</td><td valign="top" align="left" rowspan="1" colspan="1">.001</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Vigorous intensity, min/d<xref rid="zoi241717t5n4" ref-type="table-fn"><sup>d</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>&#x02009;=&#x02009;0.26</td><td valign="top" align="left" rowspan="1" colspan="1">0.04 (0.00 to 0.06)</td><td valign="top" align="left" rowspan="1" colspan="1">.01</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> MVPA, min/d<xref rid="zoi241717t5n1" ref-type="table-fn"><sup>a</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"><italic>r</italic>&#x02009;=&#x02009;0.30</td><td valign="top" align="left" rowspan="1" colspan="1">0.02 (0.00 to 0.03)</td><td valign="top" align="left" rowspan="1" colspan="1">.01</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="col" rowspan="1" colspan="1">Meeting WHO guidelines<xref rid="zoi241717t5n5" ref-type="table-fn"><sup>e</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="left" rowspan="1" colspan="1"/></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> Yes</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.94 (1.33)</td><td valign="top" align="left" rowspan="1" colspan="1">0.63 (&#x02212;0.22 to 1.48)</td><td valign="top" align="left" rowspan="1" colspan="1">.14</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1"> No</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;1.58 (1.48)</td><td valign="top" align="left" rowspan="1" colspan="1">NA </td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td><td valign="top" align="left" rowspan="1" colspan="1">NA</td></tr></tbody></table><table-wrap-foot><p>Abbreviations: FEV<sub>1</sub>, forced expiratory volume in the first second; FVC, forced vital capacity; MVPA, moderate to vigorous physical activity; NA, not applicable; NYHA, New York Heart Association; VAT, ventilatory anaerobic threshold; WHO, World Health Organization.</p><fn id="zoi241717t5n1"><label>
<sup>a</sup>
</label><p>Variables included in the multivariable analysis.</p></fn><fn id="zoi241717t5n2"><label>
<sup>b</sup>
</label><p>None of the participants had an NYHA functional class higher than II.</p></fn><fn id="zoi241717t5n3"><label>
<sup>c</sup>
</label><p>Special education enrollment indicates participant enrolled in a special school to account for their particular education status.</p></fn><fn id="zoi241717t5n4"><label>
<sup>d</sup>
</label><p>There was a strong correlation between vigorous physical activity and MVPA (<italic>r</italic>&#x02009;=&#x02009;0.87), which led us to include only MVPA in the final model.</p></fn><fn id="zoi241717t5n5"><label>
<sup>e</sup>
</label><p>WHO activity guidelines for children aged between 5 and 17 years are a mean of 60 minutes per day of moderate to vigorous intensity.</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="H1-4-ZOI241717"><title>Discussion</title><p>From a cohort of 207 children, this multicenter, prospective, controlled cross-sectional study found that children with inherited cardiac disease had lower levels of cardiopulmonary fitness than healthy controls, using the new pediatric CPET reference <italic>z</italic> scores,<sup><xref rid="zoi241717r27" ref-type="bibr">27</xref>,<xref rid="zoi241717r28" ref-type="bibr">28</xref></sup> and lower physical activity levels. Overall, the clinical, functional, sociodemographic, and behavioral parameters used in the multivariable model could explain 80% of &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max.</p><p>The &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max was significantly lower in children with inherited cardiac disease than in healthy controls, even after adjusting for use of &#x003b2;-blockers, with an absolute <italic>z</italic> score difference of &#x02212;0.69, representing a magnitude of the difference of 4.0 mL/kg/min. These results are important considering that a &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max decrease above 3.5 mL/kg/min (ie, 1 metabolic equivalent of task) is associated with a higher risk of mortality among adults.<sup><xref rid="zoi241717r46" ref-type="bibr">46</xref>,<xref rid="zoi241717r47" ref-type="bibr">47</xref></sup> Furthermore, reduced maximal workload can suggest muscular alterations (eg, fiber type, mitochondrial density, and muscle strength) in patients with inherited cardiac diseases.<sup><xref rid="zoi241717r21" ref-type="bibr">21</xref></sup></p><p>The reduced cardiopulmonary fitness level in children with inherited cardiac disease, which is an important marker of health,<sup><xref rid="zoi241717r2" ref-type="bibr">2</xref></sup> may lead to higher cardiovascular risk factors and comorbidities later in life.<sup><xref rid="zoi241717r32" ref-type="bibr">32</xref>,<xref rid="zoi241717r48" ref-type="bibr">48</xref></sup> These findings are concerning in light of established associations between reduced cardiopulmonary fitness and poor psychosocial health,<sup><xref rid="zoi241717r49" ref-type="bibr">49</xref></sup> particularly among these youths with inherited cardiac diseases in which psychosocial well-being may already be compromised.<sup><xref rid="zoi241717r50" ref-type="bibr">50</xref>,<xref rid="zoi241717r51" ref-type="bibr">51</xref></sup></p><p>Our results align with several previous findings<sup><xref rid="zoi241717r11" ref-type="bibr">11</xref>,<xref rid="zoi241717r21" ref-type="bibr">21</xref>,<xref rid="zoi241717r26" ref-type="bibr">26</xref>,<xref rid="zoi241717r52" ref-type="bibr">52</xref></sup> but offer stronger evidence from the study design, use of standardized CPET procedures, and analysis using contemporary <italic>z</italic> score pediatric reference values. The use of historical linear models for reference equations has been previously criticized, as the association between body weight and oxygen consumption is not strictly linear, particularly for individuals with extreme weight.<sup><xref rid="zoi241717r53" ref-type="bibr">53</xref>,<xref rid="zoi241717r54" ref-type="bibr">54</xref></sup> In response, new reference <italic>z</italic> score equations based on a natural logarithmic model can enhance the interpretability of individual variation with reference to normative data, while accounting for population variability in demographic factors (eg, weight and height).<sup><xref rid="zoi241717r27" ref-type="bibr">27</xref>,<xref rid="zoi241717r28" ref-type="bibr">28</xref></sup> These <italic>z</italic> score equations can also be valuable in the follow-up of patients; however, future longitudinal studies are necessary to determine which specific thresholds or changes in &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max <italic>z</italic> score over time have prognostic implications for young individuals with inherited cardiac disease.</p><p>The clinical, functional, sociodemographic, and behavioral parameters used in the multivariable model explained 80% of &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max in children with inherited heart disease. Cardiopulmonary fitness depends on respiratory, cardiac, and muscle functions, as well as anthropometric and behavioral parameters. Among the children with inherited heart disease, severe cardiac conditions (high NYHA functional class, left ventricle dilatation, or implantable cardioverter-defibrillator) were associated with a lower &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max. &#x003b2;-Blocker use was not associated with &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max, which aligns with previous findings in congenital heart disease.<sup><xref rid="zoi241717r6" ref-type="bibr">6</xref></sup> One explanation is that &#x003b2;-blocker use may also improve diastolic function and compensate for chronotropic incompetence by increasing stroke volume, as in cardiomyopathy and long QT syndrome.<sup><xref rid="zoi241717r21" ref-type="bibr">21</xref>,<xref rid="zoi241717r55" ref-type="bibr">55</xref></sup> The &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max was also associated with functional parameters, such as forced vital capacity and oxygen consumption at VAT, suggesting, respectively, restrictive lung patterns or impaired muscular fitness<sup><xref rid="zoi241717r6" ref-type="bibr">6</xref>,<xref rid="zoi241717r56" ref-type="bibr">56</xref></sup> as we observed in children with congenital heart disease<sup><xref rid="zoi241717r6" ref-type="bibr">6</xref></sup> and long QT syndrome.<sup><xref rid="zoi241717r21" ref-type="bibr">21</xref></sup></p><p>This study also highlighted the association between sociodemographic parameters and cardiopulmonary fitness among children with inherited cardiac disease. Sex, normal progression of schooling, having no siblings, and parents&#x02019; level of education were associated with &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max. The lower &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max associated with female sex can be due to body composition and blood hemoglobin concentration.<sup><xref rid="zoi241717r57" ref-type="bibr">57</xref></sup> In addition, early sex discrimination, such as sports restrictions imposed at the time of diagnosis yet not captured in this study, could also help explain this finding.<sup><xref rid="zoi241717r37" ref-type="bibr">37</xref></sup> Higher maternal educational level was associated with higher &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max<sub>,</sub> which aligns with previous findings in the general population.<sup><xref rid="zoi241717r58" ref-type="bibr">58</xref></sup></p><p>In this study, the amounts of daily moderate to vigorous physical activity and daily vigorous physical activity assessed by accelerometers were lower among patients with inherited heart disease but were not associated with &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max in the multivariable model (univariate <italic>r</italic>&#x02009;&#x02264;&#x02009;0.30), whereas a higher score on the physical activity questionnaire was associated with a higher &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max in the multivariable analysis. These findings may stem from the use of a nonvalidated questionnaire, potentially leading to an overestimation of physical activity levels.<sup><xref rid="zoi241717r59" ref-type="bibr">59</xref></sup> In addition, hereditary factors may determine up to 50% of &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max, thereby limiting the effect of physical activity.<sup><xref rid="zoi241717r60" ref-type="bibr">60</xref></sup> Last, guidelines for inherited cardiac disease recommend avoiding vigorous intensity,<sup><xref rid="zoi241717r18" ref-type="bibr">18</xref>,<xref rid="zoi241717r19" ref-type="bibr">19</xref>,<xref rid="zoi241717r20" ref-type="bibr">20</xref></sup> which is one of the more likely intensities to increase &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max.<sup><xref rid="zoi241717r61" ref-type="bibr">61</xref>,<xref rid="zoi241717r62" ref-type="bibr">62</xref></sup> Therefore, cardiopulmonary fitness and physical activity should be considered complementary but distinct health-related factors among children with inherited cardiac disease.</p><p>Motivation toward physical activity was also associated with &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max. According to the self-determination theory,<sup><xref rid="zoi241717r63" ref-type="bibr">63</xref></sup> higher extrinsic motivation externally regulated in these children (eg, running to obtain a higher grade in physical education class) may be a barrier to autonomously and enjoyably engaging in physically active behaviors in the long term,<sup><xref rid="zoi241717r11" ref-type="bibr">11</xref></sup> potentially resulting in lower &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max.</p><p>In this study, more than one-third of children with inherited cardiac disease had poor cardiopulmonary fitness (40.0% with impaired &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max), making them potentially eligible for an exercise training program. To promote physical activity, we recommend shared decision-making, taking into account the clinical, functional, sociodemographic, and behavioral profile of the child and his or her family. A multidisciplinary approach involving pediatric cardiologists, specialist nurses, and exercise physiologists could help determine the most appropriate strategy to promote physical activity while limiting life-threatening events.<sup><xref rid="zoi241717r17" ref-type="bibr">17</xref></sup> Early preventive hybrid cardiac rehabilitation programs can open new avenues for the management of youths with inherited cardiac disease, as shown in congenital heart disease.<sup><xref rid="zoi241717r4" ref-type="bibr">4</xref></sup></p><sec id="H2-12-ZOI241717"><title>Limitations</title><p>This study had several limitations. Other unmeasured variables, such as hereditary components, diet, lean body mass, weather, and school time could be associated with cardiopulmonary fitness and physical activity. The discrepancy between objective and subjective assessments of physical activity warrants further investigation, starting with exhaustive validation of a pediatric physical activity questionnaire.</p><p>Although a recent study observed good compliance with current guidelines among children with inherited cardiac disease,<sup><xref rid="zoi241717r64" ref-type="bibr">64</xref></sup> physicians&#x02019; and parents&#x02019; behaviors regarding exercise restrictions were not evaluated in this study. The heterogeneity of subgroups of patients with inherited cardiac disease restricted the analysis of conditions, such as arrhythmogenic right ventricular cardiomyopathy, that likely lead to greater sports restrictions.</p></sec></sec><sec id="H1-5-ZOI241717"><title>Conclusions</title><p>In this cross-sectional study, the levels cardiopulmonary fitness and physical activity were lower among children with inherited cardiac disease than in healthy controls, even after adjusting for use of &#x003b2;-blockers. Using contemporary and reliable pediatric CPET reference values strengthened our results and can be introduced for the follow-up of these patients over time. The clinical, functional, sociodemographic, and behavioral parameters were the multidimensional parameters associated with &#x00056;&#x00307;<sc>o</sc><sub>2</sub>max. Assessment of cardiopulmonary fitness among children with inherited cardiac disease would enable professionals to ascertain individual exercise capacities and identify suitable candidates for early cardiac rehabilitation programs by providing the appropriate exercise intensity and modality.</p></sec></body><back><ref-list id="REF-ZOI241717"><title>References</title><ref id="zoi241717r1"><label>1</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Ortega</surname>
<given-names>FB</given-names></string-name>, <string-name><surname>Ruiz</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Castillo</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Sj&#x000f6;str&#x000f6;m</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Physical fitness in childhood and adolescence: a powerful marker of health</article-title>. <source>Int J Obes (Lond)</source>. <year>2008</year>;<volume>32</volume>(<issue>1</issue>):<fpage>1</fpage>-<lpage>11</lpage>. doi:<pub-id pub-id-type="doi">10.1038/sj.ijo.0803774</pub-id>
<pub-id pub-id-type="pmid">18043605</pub-id>
</mixed-citation></ref><ref id="zoi241717r2"><label>2</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Raghuveer</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Hartz</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Lubans</surname>
<given-names>DR</given-names></string-name>, <etal/>; <collab>American Heart Association Young Hearts Athero, Hypertension and Obesity in the Young Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young</collab></person-group>. <article-title>Cardiorespiratory fitness in youth: an important marker of health: a scientific statement from the American Heart Association</article-title>. <source>Circulation</source>. <year>2020</year>;<volume>142</volume>(<issue>7</issue>):<fpage>e101</fpage>-<lpage>e118</lpage>. doi:<pub-id pub-id-type="doi">10.1161/CIR.0000000000000866</pub-id>
<pub-id pub-id-type="pmid">32686505</pub-id>
</mixed-citation></ref><ref id="zoi241717r3"><label>3</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Amedro</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Picot</surname>
<given-names>MC</given-names></string-name>, <string-name><surname>Moniotte</surname>
<given-names>S</given-names></string-name>, <etal/></person-group>. <article-title>Correlation between cardio-pulmonary exercise test variables and health-related quality of life among children with congenital heart diseases</article-title>. <source>Int J Cardiol</source>. <year>2016</year>;<volume>203</volume>:<fpage>1052</fpage>-<lpage>1060</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ijcard.2015.11.028</pub-id>
<pub-id pub-id-type="pmid">26638054</pub-id>
</mixed-citation></ref><ref id="zoi241717r4"><label>4</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Amedro</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Gavotto</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Huguet</surname>
<given-names>H</given-names></string-name>, <etal/></person-group>; QUALIREHAB Study Group. Early hybrid cardiac rehabilitation in congenital heart disease: the QUALIREHAB trial. <source>Eur Heart J</source>. 2024;45(16):1458-1473. doi:<pub-id pub-id-type="doi">10.1093/eurheartj/ehae085</pub-id><pub-id pub-id-type="pmid">38430485</pub-id>
</mixed-citation></ref><ref id="zoi241717r5"><label>5</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Duppen</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Etnel</surname>
<given-names>JR</given-names></string-name>, <string-name><surname>Spaans</surname>
<given-names>L</given-names></string-name>, <etal/></person-group>. <article-title>Does exercise training improve cardiopulmonary fitness and daily physical activity in children and young adults with corrected tetralogy of Fallot or Fontan circulation? a randomized controlled trial</article-title>. <source>Am Heart J</source>. <year>2015</year>;<volume>170</volume>(<issue>3</issue>):<fpage>606</fpage>-<lpage>614</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ahj.2015.06.018</pub-id>
<pub-id pub-id-type="pmid">26385046</pub-id>
</mixed-citation></ref><ref id="zoi241717r6"><label>6</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Amedro</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Gavotto</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Guillaumont</surname>
<given-names>S</given-names></string-name>, <etal/></person-group>. <article-title>Cardiopulmonary fitness in children with congenital heart diseases versus healthy children</article-title>. <source>Heart</source>. <year>2018</year>;<volume>104</volume>(<issue>12</issue>):<fpage>1026</fpage>-<lpage>1036</lpage>. doi:<pub-id pub-id-type="doi">10.1136/heartjnl-2017-312339</pub-id>
<pub-id pub-id-type="pmid">29170358</pub-id>
</mixed-citation></ref><ref id="zoi241717r7"><label>7</label><mixed-citation publication-type="journal"><person-group><string-name><surname>H&#x000f6;gstr&#x000f6;m</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Nordstr&#x000f6;m</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Nordstr&#x000f6;m</surname>
<given-names>P</given-names></string-name></person-group>. <article-title>High aerobic fitness in late adolescence is associated with a reduced risk of myocardial infarction later in life: a nationwide cohort study in men</article-title>. <source>Eur Heart J</source>. <year>2014</year>;<volume>35</volume>(<issue>44</issue>):<fpage>3133</fpage>-<lpage>3140</lpage>. doi:<pub-id pub-id-type="doi">10.1093/eurheartj/eht527</pub-id>
<pub-id pub-id-type="pmid">24398666</pub-id>
</mixed-citation></ref><ref id="zoi241717r8"><label>8</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Henriksson</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Henriksson</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Tynelius</surname>
<given-names>P</given-names></string-name>, <etal/></person-group>. <article-title>Cardiorespiratory fitness, muscular strength, and obesity in adolescence and later chronic disability due to cardiovascular disease: a cohort study of 1 million men</article-title>. <source>Eur Heart J</source>. <year>2020</year>;<volume>41</volume>(<issue>15</issue>):<fpage>1503</fpage>-<lpage>1510</lpage>. doi:<pub-id pub-id-type="doi">10.1093/eurheartj/ehz774</pub-id>
<pub-id pub-id-type="pmid">31710669</pub-id>
</mixed-citation></ref><ref id="zoi241717r9"><label>9</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Saha</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Potiny</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Rigdon</surname>
<given-names>J</given-names></string-name>, <etal/></person-group>. <article-title>Substantial cardiovascular morbidity in adults with lower-complexity congenital heart disease</article-title>. <source>Circulation</source>. <year>2019</year>;<volume>139</volume>(<issue>16</issue>):<fpage>1889</fpage>-<lpage>1899</lpage>. doi:<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.118.037064</pub-id>
<pub-id pub-id-type="pmid">30813762</pub-id>
</mixed-citation></ref><ref id="zoi241717r10"><label>10</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Rhodes</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Curran</surname>
<given-names>TJ</given-names></string-name>, <string-name><surname>Camil</surname>
<given-names>L</given-names></string-name>, <etal/></person-group>. <article-title>Impact of cardiac rehabilitation on the exercise function of children with serious congenital heart disease</article-title>. <source>Pediatrics</source>. <year>2005</year>;<volume>116</volume>(<issue>6</issue>):<fpage>1339</fpage>-<lpage>1345</lpage>. doi:<pub-id pub-id-type="doi">10.1542/peds.2004-2697</pub-id>
<pub-id pub-id-type="pmid">16322156</pub-id>
</mixed-citation></ref><ref id="zoi241717r11"><label>11</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Moncion</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Gardin</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Lougheed</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Adamo</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Longmuir</surname>
<given-names>PE</given-names></string-name></person-group>. <article-title>Children with cardiomyopathy have active lifestyles despite reporting disease-specific barriers to physical activity: a mixed-methods study</article-title>. <source>Exerc Med</source>. <year>2022</year>;<volume>6</volume>:4. doi:<pub-id pub-id-type="doi">10.26644/em.2022.004</pub-id>
</mixed-citation></ref><ref id="zoi241717r12"><label>12</label><mixed-citation publication-type="journal"><person-group><string-name><surname>van Deutekom</surname>
<given-names>AW</given-names></string-name>, <string-name><surname>Lewandowski</surname>
<given-names>AJ</given-names></string-name></person-group>. <article-title>Physical activity modification in youth with congenital heart disease: a comprehensive narrative review</article-title>. <source>Pediatr Res</source>. <year>2021</year>;<volume>89</volume>(<issue>7</issue>):<fpage>1650</fpage>-<lpage>1658</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41390-020-01194-8</pub-id>
<pub-id pub-id-type="pmid">33049756</pub-id>
</mixed-citation></ref><ref id="zoi241717r13"><label>13</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Christian</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Somerville</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Giuffre</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Atallah</surname>
<given-names>J</given-names></string-name></person-group>. <article-title>Physical activity restriction for children and adolescents diagnosed with an inherited arrhythmia or cardiomyopathy and its impact on body mass index</article-title>. <source>J Cardiovasc Electrophysiol</source>. <year>2018</year>;<volume>29</volume>(<issue>12</issue>):<fpage>1648</fpage>-<lpage>1653</lpage>. doi:<pub-id pub-id-type="doi">10.1111/jce.13713</pub-id>
<pub-id pub-id-type="pmid">30106210</pub-id>
</mixed-citation></ref><ref id="zoi241717r14"><label>14</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Pelliccia</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Fagard</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Bj&#x000f8;rnstad</surname>
<given-names>HH</given-names></string-name>, <etal/>; <collab>Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology</collab>; <collab>Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology</collab></person-group>. <article-title>Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology</article-title>. <source>Eur Heart J</source>. <year>2005</year>;<volume>26</volume>(<issue>14</issue>):<fpage>1422</fpage>-<lpage>1445</lpage>. doi:<pub-id pub-id-type="doi">10.1093/eurheartj/ehi325</pub-id>
<pub-id pub-id-type="pmid">15923204</pub-id>
</mixed-citation></ref><ref id="zoi241717r15"><label>15</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Maron</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Zipes</surname>
<given-names>DP</given-names></string-name></person-group>. <article-title>Introduction: eligibility recommendations for competitive athletes with cardiovascular abnormalities&#x02014;general considerations</article-title>. <source>J Am Coll Cardiol</source>. <year>2005</year>;<volume>45</volume>(<issue>8</issue>):<fpage>1318</fpage>-<lpage>1321</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jacc.2005.02.006</pub-id>
<pub-id pub-id-type="pmid">15837280</pub-id>
</mixed-citation></ref><ref id="zoi241717r16"><label>16</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Maron</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Mitchell</surname>
<given-names>JH</given-names></string-name></person-group>. <article-title>26th Bethesda Conference: recommendations for determining eligibility for competition in athletes with cardiovascular abnormalities: January 6-7, 1994</article-title>. <source>J Am Coll Cardiol</source>. <year>1994</year>;<volume>24</volume>(<issue>4</issue>):<fpage>845</fpage>-<lpage>899</lpage>. doi:<pub-id pub-id-type="doi">10.1016/0735-1097(94)90836-2</pub-id>
<pub-id pub-id-type="pmid">7798484</pub-id>
</mixed-citation></ref><ref id="zoi241717r17"><label>17</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Lampert</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Chung</surname>
<given-names>EH</given-names></string-name>, <string-name><surname>Ackerman</surname>
<given-names>MJ</given-names></string-name>, <etal/></person-group>. 2024 HRS expert consensus statement on arrhythmias in the athlete: evaluation, treatment, and return to play. <source>Heart Rhythm</source>. <year>2024</year>;21(10):e151-e252. doi:<pub-id pub-id-type="doi">10.1016/j.hrthm.2024.05.018</pub-id><pub-id pub-id-type="pmid">38763377</pub-id>
</mixed-citation></ref><ref id="zoi241717r18"><label>18</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Pelliccia</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Sharma</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gati</surname>
<given-names>S</given-names></string-name>, <etal/>; <collab>ESC Scientific Document Group</collab></person-group>. <article-title>2020 ESC guidelines on sports cardiology and exercise in patients with cardiovascular disease</article-title>. <source>Eur Heart J</source>. <year>2021</year>;<volume>42</volume>(<issue>1</issue>):<fpage>17</fpage>-<lpage>96</lpage>. doi:<pub-id pub-id-type="doi">10.1093/eurheartj/ehaa605</pub-id>
<pub-id pub-id-type="pmid">32860412</pub-id>
</mixed-citation></ref><ref id="zoi241717r19"><label>19</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Ackerman</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Zipes</surname>
<given-names>DP</given-names></string-name>, <string-name><surname>Kovacs</surname>
<given-names>RJ</given-names></string-name>, <string-name><surname>Maron</surname>
<given-names>BJ</given-names></string-name>; <collab>American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and American College of Cardiology</collab></person-group>. <article-title>Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 10: the cardiac channelopathies: a scientific statement from the American Heart Association and American College of Cardiology</article-title>. <source>Circulation</source>. <year>2015</year>;<volume>132</volume>(<issue>22</issue>):<fpage>e326</fpage>-<lpage>e329</lpage>. doi:<pub-id pub-id-type="doi">10.1161/CIR.0000000000000246</pub-id>
<pub-id pub-id-type="pmid">26527716</pub-id>
</mixed-citation></ref><ref id="zoi241717r20"><label>20</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Maron</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Udelson</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Bonow</surname>
<given-names>RO</given-names></string-name>, <etal/></person-group>. <article-title>Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology</article-title>. <source>J Am Coll Cardiol</source>. <year>2015</year>;<volume>66</volume>(<issue>21</issue>):<fpage>2362</fpage>-<lpage>2371</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jacc.2015.09.035</pub-id>
<pub-id pub-id-type="pmid">26542657</pub-id>
</mixed-citation></ref><ref id="zoi241717r21"><label>21</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Souilla</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Avesani</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Boisson</surname>
<given-names>A</given-names></string-name>, <etal/></person-group>. <article-title>Cardiorespiratory fitness, muscle fitness, and physical activity in children with long QT syndrome: a prospective controlled study</article-title>. <source>Front Cardiovasc Med</source>. <year>2023</year>;<volume>9</volume>:<elocation-id>1081106</elocation-id>. doi:<pub-id pub-id-type="doi">10.3389/fcvm.2022.1081106</pub-id>
<pub-id pub-id-type="pmid">36712265</pub-id>
</mixed-citation></ref><ref id="zoi241717r22"><label>22</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Chen</surname>
<given-names>CH</given-names></string-name>, <string-name><surname>De Souza</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Franciosi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Harris</surname>
<given-names>KC</given-names></string-name>, <string-name><surname>Sanatani</surname>
<given-names>S</given-names></string-name></person-group>. <article-title>Physical activity in paediatric long QT syndrome patients</article-title>. <source>CJC Pediatr Congenit Heart Dis</source>. <year>2022</year>;<volume>1</volume>(<issue>2</issue>):<fpage>80</fpage>-<lpage>85</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.cjcpc.2021.12.001</pub-id>
<pub-id pub-id-type="pmid">38058492</pub-id>
</mixed-citation></ref><ref id="zoi241717r23"><label>23</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Teber</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Saglam</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Ertugrul</surname>
<given-names>I</given-names></string-name>, <etal/></person-group>. <article-title>Levels of physical activity and physical fitness in pediatric pacemaker patients: a cross-sectional study</article-title>. <source>Pediatr Cardiol</source>. <year>2020</year>;<volume>41</volume>(<issue>7</issue>):<fpage>1363</fpage>-<lpage>1369</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00246-020-02384-1</pub-id>
<pub-id pub-id-type="pmid">32474736</pub-id>
</mixed-citation></ref><ref id="zoi241717r24"><label>24</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Cunningham</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Spence</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Stearns</surname>
<given-names>JA</given-names></string-name>, <etal/></person-group>. <article-title>Self-reported and accelerometer-measured physical activity in children with cardiomyopathy</article-title>. <source>J Cardiovasc Nurs</source>. <year>2020</year>;<volume>35</volume>(<issue>3</issue>):<fpage>300</fpage>-<lpage>306</lpage>. doi:<pub-id pub-id-type="doi">10.1097/JCN.0000000000000629</pub-id>
<pub-id pub-id-type="pmid">31904691</pub-id>
</mixed-citation></ref><ref id="zoi241717r25"><label>25</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Christian</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Somerville</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Taylor</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Spence</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Giuffre</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Atallah</surname>
<given-names>J</given-names></string-name></person-group>. <article-title>The impact of physical activity modification on the well-being of a cohort of children with an inherited arrhythmia or cardiomyopathy</article-title>. <source>Cardiol Young</source>. <year>2020</year>;<volume>30</volume>(<issue>5</issue>):<fpage>692</fpage>-<lpage>697</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S1047951120000803</pub-id>
<pub-id pub-id-type="pmid">32286207</pub-id>
</mixed-citation></ref><ref id="zoi241717r26"><label>26</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Edelson</surname>
<given-names>JB</given-names></string-name>, <string-name><surname>Stanley</surname>
<given-names>HM</given-names></string-name>, <string-name><surname>Min</surname>
<given-names>J</given-names></string-name>, <etal/></person-group>. <article-title>Cardiopulmonary exercise testing in pediatric patients with hypertrophic cardiomyopathy</article-title>. <source>JACC Adv</source>. <year>2022</year>;<volume>1</volume>(<issue>4</issue>):<elocation-id>100107</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.jacadv.2022.100107</pub-id>
<pub-id pub-id-type="pmid">38939702</pub-id>
</mixed-citation></ref><ref id="zoi241717r27"><label>27</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Amedro</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Matecki</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Pereira Dos Santos</surname>
<given-names>T</given-names></string-name>, <etal/></person-group>. <article-title>Reference values of cardiopulmonary exercise test parameters in the contemporary paediatric population</article-title>. <source>Sports Med Open</source>. <year>2023</year>;<volume>9</volume>(<issue>1</issue>):<fpage>68</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s40798-023-00622-3</pub-id>
<pub-id pub-id-type="pmid">37528295</pub-id>
</mixed-citation></ref><ref id="zoi241717r28"><label>28</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Gavotto</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Mura</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Rhodes</surname>
<given-names>J</given-names></string-name>, <etal/></person-group>. <article-title>Reference values of aerobic fitness in the contemporary paediatric population</article-title>. <source>Eur J Prev Cardiol</source>. <year>2023</year>;<volume>30</volume>(<issue>9</issue>):<fpage>820</fpage>-<lpage>829</lpage>. doi:<pub-id pub-id-type="doi">10.1093/eurjpc/zwad054</pub-id>
<pub-id pub-id-type="pmid">36809338</pub-id>
</mixed-citation></ref><ref id="zoi241717r29"><label>29</label><mixed-citation publication-type="journal"><person-group><collab>World Medical Association</collab></person-group>. <article-title>World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects</article-title>. <source>JAMA</source>. <year>2013</year>;<volume>310</volume>(<issue>20</issue>):<fpage>2191</fpage>-<lpage>2194</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jama.2013.281053</pub-id>
<pub-id pub-id-type="pmid">24141714</pub-id>
</mixed-citation></ref><ref id="zoi241717r30"><label>30</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Amedro</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Werner</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Abassi</surname>
<given-names>H</given-names></string-name>, <etal/></person-group>. <article-title>Health-related quality of life and physical activity in children with inherited cardiac arrhythmia or inherited cardiomyopathy: the prospective multicentre controlled QUALIMYORYTHM study rationale, design and methods</article-title>. <source>Health Qual Life Outcomes</source>. <year>2021</year>;<volume>19</volume>(<issue>1</issue>):<fpage>187</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12955-021-01825-6</pub-id>
<pub-id pub-id-type="pmid">34321045</pub-id>
</mixed-citation></ref><ref id="zoi241717r31"><label>31</label><mixed-citation publication-type="journal"><person-group><string-name><surname>von Elm</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Altman</surname>
<given-names>DG</given-names></string-name>, <string-name><surname>Egger</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Pocock</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>G&#x000f8;tzsche</surname>
<given-names>PC</given-names></string-name>, <string-name><surname>Vandenbroucke</surname>
<given-names>JP</given-names></string-name>; <collab>STROBE Initiative</collab></person-group>. <article-title>The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies</article-title>. <source>Lancet</source>. <year>2007</year>;<volume>370</volume>(<issue>9596</issue>):<fpage>1453</fpage>-<lpage>1457</lpage>. doi:<pub-id pub-id-type="doi">10.1016/S0140-6736(07)61602-X</pub-id>
<pub-id pub-id-type="pmid">18064739</pub-id>
</mixed-citation></ref><ref id="zoi241717r32"><label>32</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Garc&#x000ed;a-Hermoso</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Ram&#x000ed;rez-V&#x000e9;lez</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Garc&#x000ed;a-Alonso</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Alonso-Mart&#x000ed;nez</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Izquierdo</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Association of cardiorespiratory fitness levels during youth with health risk later in life: a systematic review and meta-analysis</article-title>. <source>JAMA Pediatr</source>. <year>2020</year>;<volume>174</volume>(<issue>10</issue>):<fpage>952</fpage>-<lpage>960</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamapediatrics.2020.2400</pub-id>
<pub-id pub-id-type="pmid">32870243</pub-id>
</mixed-citation></ref><ref id="zoi241717r33"><label>33</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Beaver</surname>
<given-names>WL</given-names></string-name>, <string-name><surname>Wasserman</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Whipp</surname>
<given-names>BJ</given-names></string-name></person-group>. A new method for detecting anaerobic threshold by gas exchange. <source>J Appl Physiol (1985)</source>. <year>1986</year>;60(6):2020-2027. doi:<pub-id pub-id-type="doi">10.1152/jappl.1986.60.6.2020</pub-id><pub-id pub-id-type="pmid">3087938</pub-id>
</mixed-citation></ref><ref id="zoi241717r34"><label>34</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Cooper</surname>
<given-names>DM</given-names></string-name>, <string-name><surname>Weiler-Ravell</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Whipp</surname>
<given-names>BJ</given-names></string-name>, <string-name><surname>Wasserman</surname>
<given-names>K</given-names></string-name></person-group>. <article-title>Aerobic parameters of exercise as a function of body size during growth in children</article-title>. <source>J Appl Physiol Respir Environ Exerc Physiol</source>. <year>1984</year>;<volume>56</volume>(<issue>3</issue>):<fpage>628</fpage>-<lpage>634</lpage>. doi:<pub-id pub-id-type="doi">10.1152/jappl.1984.56.3.628</pub-id>
<pub-id pub-id-type="pmid">6706770</pub-id>
</mixed-citation></ref><ref id="zoi241717r35"><label>35</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Cooper</surname>
<given-names>AR</given-names></string-name>, <string-name><surname>Goodman</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Page</surname>
<given-names>AS</given-names></string-name>, <etal/></person-group>. <article-title>Objectively measured physical activity and sedentary time in youth: the International Children&#x02019;s Accelerometry Database (ICAD)</article-title>. <source>Int J Behav Nutr Phys Act</source>. <year>2015</year>;<volume>12</volume>:<fpage>113</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12966-015-0274-5</pub-id>
<pub-id pub-id-type="pmid">26377803</pub-id>
</mixed-citation></ref><ref id="zoi241717r36"><label>36</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Evenson</surname>
<given-names>KR</given-names></string-name>, <string-name><surname>Catellier</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Gill</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Ondrak</surname>
<given-names>KS</given-names></string-name>, <string-name><surname>McMurray</surname>
<given-names>RG</given-names></string-name></person-group>. <article-title>Calibration of two objective measures of physical activity for children</article-title>. <source>J Sports Sci</source>. <year>2008</year>;<volume>26</volume>(<issue>14</issue>):<fpage>1557</fpage>-<lpage>1565</lpage>. doi:<pub-id pub-id-type="doi">10.1080/02640410802334196</pub-id>
<pub-id pub-id-type="pmid">18949660</pub-id>
</mixed-citation></ref><ref id="zoi241717r37"><label>37</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Voss</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Duncombe</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Dean</surname>
<given-names>PH</given-names></string-name>, <string-name><surname>de Souza</surname>
<given-names>AM</given-names></string-name>, <string-name><surname>Harris</surname>
<given-names>KC</given-names></string-name></person-group>. <article-title>Physical activity and sedentary behavior in children with congenital heart disease</article-title>. <source>J Am Heart Assoc</source>. <year>2017</year>;<volume>6</volume>(<issue>3</issue>):<elocation-id>e004665</elocation-id>. doi:<pub-id pub-id-type="doi">10.1161/JAHA.116.004665</pub-id>
<pub-id pub-id-type="pmid">28264859</pub-id>
</mixed-citation></ref><ref id="zoi241717r38"><label>38</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Vuillemin</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Denis</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Guillemin</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Jeandel</surname>
<given-names>C</given-names></string-name></person-group>. <article-title>A review of evaluation questionnaires for physical activity</article-title>. Article in French. <source>Rev Epidemiol Sante Publique</source>. <year>1998</year>;<volume>46</volume>(<issue>1</issue>):<fpage>49</fpage>-<lpage>55</lpage>.<pub-id pub-id-type="pmid">9533234</pub-id>
</mixed-citation></ref><ref id="zoi241717r39"><label>39</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Boich&#x000e9;</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Gourlan</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Trouilloud</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Sarrazin</surname>
<given-names>P</given-names></string-name></person-group>. <article-title>Development and validation of the &#x0201c;Echelle de Motivation envers l&#x02019;Activit&#x000e9; Physique en contexte de Sant&#x000e9;&#x0201d;: a motivation scale towards health-oriented physical activity in French</article-title>. <source>J Health Psychol</source>. <year>2019</year>;<volume>24</volume>(<issue>3</issue>):<fpage>386</fpage>-<lpage>396</lpage>. doi:<pub-id pub-id-type="doi">10.1177/1359105316676626</pub-id>
<pub-id pub-id-type="pmid">27872385</pub-id>
</mixed-citation></ref><ref id="zoi241717r40"><label>40</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Amedro</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Huguet</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Macioce</surname>
<given-names>V</given-names></string-name>, <etal/></person-group>. <article-title>Psychometric validation of the French self and proxy versions of the PedsQL&#x02122; 4.0 generic health-related quality of life questionnaire for 8-12 year-old children</article-title>. <source>Health Qual Life Outcomes</source>. <year>2021</year>;<volume>19</volume>(<issue>1</issue>):<fpage>75</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12955-021-01714-y</pub-id>
<pub-id pub-id-type="pmid">33663527</pub-id>
</mixed-citation></ref><ref id="zoi241717r41"><label>41</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Varni</surname>
<given-names>JW</given-names></string-name>, <string-name><surname>Seid</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kurtin</surname>
<given-names>PS</given-names></string-name></person-group>. PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations. <source>Med Care</source>. <year>2001</year>;<volume>39</volume>(<issue>8</issue>):<fpage>800</fpage>-<lpage>812</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00005650-200108000-00006</pub-id>
<pub-id pub-id-type="pmid">11468499</pub-id>
</mixed-citation></ref><ref id="zoi241717r42"><label>42</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Abassi</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Huguet</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Picot</surname>
<given-names>MC</given-names></string-name>, <etal/></person-group>. <article-title>Health-related quality of life in children with congenital heart disease aged 5 to 7 years: a multicentre controlled cross-sectional study</article-title>. <source>Health Qual Life Outcomes</source>. <year>2020</year>;<volume>18</volume>(<issue>1</issue>):<fpage>366</fpage>. doi:<pub-id pub-id-type="doi">10.1186/s12955-020-01615-6</pub-id>
<pub-id pub-id-type="pmid">33183312</pub-id>
</mixed-citation></ref><ref id="zoi241717r43"><label>43</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Abassi</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Bajolle</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Werner</surname>
<given-names>O</given-names></string-name>, <etal/></person-group>. <article-title>Health-related quality of life correlates with time in therapeutic range in children on anticoagulants with international normalised ratio self-monitoring</article-title>. <source>Arch Cardiovasc Dis</source>. <year>2020</year>;<volume>113</volume>(<issue>12</issue>):<fpage>811</fpage>-<lpage>820</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.acvd.2020.05.022</pub-id>
<pub-id pub-id-type="pmid">33069639</pub-id>
</mixed-citation></ref><ref id="zoi241717r44"><label>44</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Amedro</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Dorka</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Moniotte</surname>
<given-names>S</given-names></string-name>, <etal/></person-group>. <article-title>Quality of life of children with congenital heart diseases: a multicenter controlled cross-sectional study</article-title>. <source>Pediatr Cardiol</source>. <year>2015</year>;<volume>36</volume>(<issue>8</issue>):<fpage>1588</fpage>-<lpage>1601</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00246-015-1201-x</pub-id>
<pub-id pub-id-type="pmid">26024647</pub-id>
</mixed-citation></ref><ref id="zoi241717r45"><label>45</label><mixed-citation publication-type="webpage">World Health Organization. <italic>WHO Guidelines on Physical Activity and Sedentary Behaviour</italic>. World Health Organization; 2020. Accessed February 20, 2021. <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK566045/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/books/NBK566045/</ext-link></mixed-citation></ref><ref id="zoi241717r46"><label>46</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Kokkinos</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Faselis</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Samuel</surname>
<given-names>IBH</given-names></string-name>, <etal/></person-group>. <article-title>Changes in cardiorespiratory fitness and survival in patients with or without cardiovascular disease</article-title>. <source>J Am Coll Cardiol</source>. <year>2023</year>;<volume>81</volume>(<issue>12</issue>):<fpage>1137</fpage>-<lpage>1147</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jacc.2023.01.027</pub-id>
<pub-id pub-id-type="pmid">36948729</pub-id>
</mixed-citation></ref><ref id="zoi241717r47"><label>47</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Laukkanen</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>Isiozor</surname>
<given-names>NM</given-names></string-name>, <string-name><surname>Kunutsor</surname>
<given-names>SK</given-names></string-name></person-group>. <article-title>Objectively assessed cardiorespiratory fitness and all-cause mortality risk: an updated meta-analysis of 37 cohort studies involving 2,258,029 participants</article-title>. <source>Mayo Clin Proc</source>. <year>2022</year>;<volume>97</volume>(<issue>6</issue>):<fpage>1054</fpage>-<lpage>1073</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.mayocp.2022.02.029</pub-id>
<pub-id pub-id-type="pmid">35562197</pub-id>
</mixed-citation></ref><ref id="zoi241717r48"><label>48</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Mintjens</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Menting</surname>
<given-names>MD</given-names></string-name>, <string-name><surname>Daams</surname>
<given-names>JG</given-names></string-name>, <string-name><surname>van Poppel</surname>
<given-names>MNM</given-names></string-name>, <string-name><surname>Roseboom</surname>
<given-names>TJ</given-names></string-name>, <string-name><surname>Gemke</surname>
<given-names>RJBJ</given-names></string-name></person-group>. <article-title>Cardiorespiratory fitness in childhood and adolescence affects future cardiovascular risk factors: a systematic review of longitudinal studies</article-title>. <source>Sports Med</source>. <year>2018</year>;<volume>48</volume>(<issue>11</issue>):<fpage>2577</fpage>-<lpage>2605</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s40279-018-0974-5</pub-id>
<pub-id pub-id-type="pmid">30144022</pub-id>
</mixed-citation></ref><ref id="zoi241717r49"><label>49</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Chiang</surname>
<given-names>HL</given-names></string-name>, <string-name><surname>Chuang</surname>
<given-names>YF</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>YA</given-names></string-name>, <etal/></person-group>. <article-title>Physical fitness and risk of mental disorders in children and adolescents</article-title>. <source>JAMA Pediatr</source>. <year>2024</year>;<volume>178</volume>(<issue>6</issue>):<fpage>595</fpage>-<lpage>607</lpage>. doi:<pub-id pub-id-type="doi">10.1001/jamapediatrics.2024.0806</pub-id>
<pub-id pub-id-type="pmid">38683586</pub-id>
</mixed-citation></ref><ref id="zoi241717r50"><label>50</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Potterton</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Shaughnessy</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Wootton</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Sharma</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Wray</surname>
<given-names>J</given-names></string-name></person-group>. <article-title>The psychological impact of the diagnostic pathway for inherited cardiac conditions in children and adolescents: a systematic review of the literature</article-title>. <source>Prog Pediatr Cardiol</source>. <year>2024</year>;<volume>72</volume>:<elocation-id>101702</elocation-id>. doi:<pub-id pub-id-type="doi">10.1016/j.ppedcard.2023.101702</pub-id>
</mixed-citation></ref><ref id="zoi241717r51"><label>51</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Spanaki</surname>
<given-names>A</given-names></string-name>, <string-name><surname>O&#x02019;Curry</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Winter-Beatty</surname>
<given-names>J</given-names></string-name>, <etal/></person-group>. <article-title>Psychosocial adjustment and quality of life in children undergoing screening in a specialist paediatric hypertrophic cardiomyopathy clinic</article-title>. <source>Cardiol Young</source>. <year>2016</year>;<volume>26</volume>(<issue>5</issue>):<fpage>961</fpage>-<lpage>967</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S1047951115001717</pub-id>
<pub-id pub-id-type="pmid">26346425</pub-id>
</mixed-citation></ref><ref id="zoi241717r52"><label>52</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Przybylski</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Fischer</surname>
<given-names>IR</given-names></string-name>, <string-name><surname>Gauvreau</surname>
<given-names>K</given-names></string-name>, <etal/></person-group>. <article-title>Assessment of exercise function in children and young adults with hypertrophic cardiomyopathy and correlation with transthoracic echocardiographic parameters</article-title>. <source>Pediatr Cardiol</source>. <year>2022</year>;<volume>43</volume>(<issue>5</issue>):<fpage>1037</fpage>-<lpage>1045</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s00246-022-02822-2</pub-id>
<pub-id pub-id-type="pmid">35059780</pub-id>
</mixed-citation></ref><ref id="zoi241717r53"><label>53</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Welsman</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Armstrong</surname>
<given-names>N</given-names></string-name></person-group>. <article-title>Interpreting aerobic fitness in youth: the fallacy of ratio scaling</article-title>. <source>Pediatr Exerc Sci</source>. <year>2019</year>;<volume>31</volume>(<issue>2</issue>):<fpage>184</fpage>-<lpage>190</lpage>. doi:<pub-id pub-id-type="doi">10.1123/pes.2018-0141</pub-id>
<pub-id pub-id-type="pmid">30332906</pub-id>
</mixed-citation></ref><ref id="zoi241717r54"><label>54</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Tanner</surname>
<given-names>JM</given-names></string-name></person-group>. <article-title>Fallacy of per-weight and per-surface area standards, and their relation to spurious correlation</article-title>. <source>J Appl Physiol</source>. <year>1949</year>;<volume>2</volume>(<issue>1</issue>):<fpage>1</fpage>-<lpage>15</lpage>. doi:<pub-id pub-id-type="doi">10.1152/jappl.1949.2.1.1</pub-id>
<pub-id pub-id-type="pmid">18133122</pub-id>
</mixed-citation></ref><ref id="zoi241717r55"><label>55</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Bratt</surname>
<given-names>EL</given-names></string-name>, <string-name><surname>&#x000d6;stman-Smith</surname>
<given-names>I</given-names></string-name></person-group>. <article-title>Effects of lifestyle changes and high-dose &#x003b2;-blocker therapy on exercise capacity in children, adolescents, and young adults with hypertrophic cardiomyopathy</article-title>. <source>Cardiol Young</source>. <year>2015</year>;<volume>25</volume>(<issue>3</issue>):<fpage>501</fpage>-<lpage>510</lpage>. doi:<pub-id pub-id-type="doi">10.1017/S1047951114000237</pub-id>
<pub-id pub-id-type="pmid">24607033</pub-id>
</mixed-citation></ref><ref id="zoi241717r56"><label>56</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Van Brussel</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Bongers</surname>
<given-names>BC</given-names></string-name>, <string-name><surname>Hulzebos</surname>
<given-names>EHJ</given-names></string-name>, <string-name><surname>Burghard</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Takken</surname>
<given-names>T</given-names></string-name></person-group>. <article-title>A systematic approach to interpreting the cardiopulmonary exercise test in pediatrics</article-title>. <source>Pediatr Exerc Sci</source>. <year>2019</year>;<volume>31</volume>(<issue>2</issue>):<fpage>194</fpage>-<lpage>203</lpage>. doi:<pub-id pub-id-type="doi">10.1123/pes.2018-0235</pub-id>
<pub-id pub-id-type="pmid">30691356</pub-id>
</mixed-citation></ref><ref id="zoi241717r57"><label>57</label><mixed-citation publication-type="book"><person-group><string-name><surname>Armstrong</surname>
<given-names>N</given-names></string-name>, <string-name><surname>McManus</surname>
<given-names>A</given-names></string-name></person-group>. Aerobic fitness. In: Armstrong N, van Mechelen W, eds. <italic>Children&#x02019;s Sport and Exercise Medicine</italic>. Oxford Press; <year>2017</year>:<fpage>161</fpage>-<lpage>180</lpage>, </mixed-citation></ref><ref id="zoi241717r58"><label>58</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Reina-Guti&#x000e9;rrez</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Mart&#x000ed;nez-Vizca&#x000ed;no</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Torres-Costoso</surname>
<given-names>A</given-names></string-name>, <string-name><surname>N&#x000fa;&#x000f1;ez de Arenas-Arroyo</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Saz-Lara</surname>
<given-names>A</given-names></string-name>, <string-name><surname>S&#x000e1;nchez-L&#x000f3;pez</surname>
<given-names>M</given-names></string-name></person-group>. <article-title>Maternal education and academic achievement in schoolchildren: the role of cardiorespiratory fitness</article-title>. <source>J Pediatr</source>. <year>2021</year>;<volume>232</volume>:<fpage>109</fpage>-<lpage>117</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jpeds.2021.01.047</pub-id>
<pub-id pub-id-type="pmid">33515556</pub-id>
</mixed-citation></ref><ref id="zoi241717r59"><label>59</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Hidding</surname>
<given-names>LM</given-names></string-name>, <string-name><surname>Chinapaw</surname>
<given-names>MJM</given-names></string-name>, <string-name><surname>van Poppel</surname>
<given-names>MNM</given-names></string-name>, <string-name><surname>Mokkink</surname>
<given-names>LB</given-names></string-name>, <string-name><surname>Altenburg</surname>
<given-names>TM</given-names></string-name></person-group>. <article-title>An updated systematic review of childhood physical activity questionnaires</article-title>. <source>Sports Med</source>. <year>2018</year>;<volume>48</volume>(<issue>12</issue>):<fpage>2797</fpage>-<lpage>2842</lpage>. doi:<pub-id pub-id-type="doi">10.1007/s40279-018-0987-0</pub-id>
<pub-id pub-id-type="pmid">30298479</pub-id>
</mixed-citation></ref><ref id="zoi241717r60"><label>60</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Bouchard</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Daw</surname>
<given-names>EW</given-names></string-name>, <string-name><surname>Rice</surname>
<given-names>T</given-names></string-name>, <etal/></person-group>. <article-title>Familial resemblance for VO<sub>2max</sub> in the sedentary state: the HERITAGE Family Study</article-title>. <source>Med Sci Sports Exerc</source>. <year>1998</year>;<volume>30</volume>(<issue>2</issue>):<fpage>252</fpage>-<lpage>258</lpage>. doi:<pub-id pub-id-type="doi">10.1097/00005768-199802000-00013</pub-id>
<pub-id pub-id-type="pmid">9502354</pub-id>
</mixed-citation></ref><ref id="zoi241717r61"><label>61</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Armstrong</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Tomkinson</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Ekelund</surname>
<given-names>U</given-names></string-name></person-group>. <article-title>Aerobic fitness and its relationship to sport, exercise training and habitual physical activity during youth</article-title>. <source>Br J Sports Med</source>. <year>2011</year>;<volume>45</volume>(<issue>11</issue>):<fpage>849</fpage>-<lpage>858</lpage>. doi:<pub-id pub-id-type="doi">10.1136/bjsports-2011-090200</pub-id>
<pub-id pub-id-type="pmid">21836169</pub-id>
</mixed-citation></ref><ref id="zoi241717r62"><label>62</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Burden</surname>
<given-names>SJ</given-names></string-name>, <string-name><surname>Weedon</surname>
<given-names>BD</given-names></string-name>, <string-name><surname>Turner</surname>
<given-names>A</given-names></string-name>, <etal/></person-group>. <article-title>Intensity and duration of physical activity and cardiorespiratory fitness</article-title>. <source>Pediatrics</source>. <year>2022</year>;<volume>150</volume>(<issue>1</issue>):<elocation-id>e2021056003</elocation-id>. doi:<pub-id pub-id-type="doi">10.1542/peds.2021-056003</pub-id>
<pub-id pub-id-type="pmid">35694877</pub-id>
</mixed-citation></ref><ref id="zoi241717r63"><label>63</label><mixed-citation publication-type="book"><person-group><string-name><surname>Deci</surname>
<given-names>EL</given-names></string-name>, <string-name><surname>Ryan</surname>
<given-names>RM</given-names></string-name></person-group>. <source>Intrinsic Motivation and Self-Determination in Human Behavior</source>. <publisher-name>Springer Science &#x00026; Business Media</publisher-name>; <year>1985</year>. doi:<pub-id pub-id-type="doi">10.1007/978-1-4899-2271-7</pub-id>
</mixed-citation></ref><ref id="zoi241717r64"><label>64</label><mixed-citation publication-type="journal"><person-group><string-name><surname>Boisson</surname>
<given-names>A</given-names></string-name>, <string-name><surname>De La Villeon</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Huguet</surname>
<given-names>H</given-names></string-name>, <etal/></person-group>. <article-title>Physical activity and aerobic fitness in children with inherited cardiac diseases</article-title>. <source>Arch Cardiovasc Dis</source>. <year>2021</year>;<volume>114</volume>(<issue>11</issue>):<fpage>727</fpage>-<lpage>736</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.acvd.2021.07.004</pub-id>
<pub-id pub-id-type="pmid">34756533</pub-id>
</mixed-citation></ref></ref-list><notes notes-type="supplementary-material" id="note-ZOI241717-1"><supplementary-material id="note-ZOI241717-1-s" position="float" content-type="local-data"><label>Supplement 1.</label><caption><p><bold>eAppendix.</bold> Additional Study Assessment</p><p>
eReferences.
</p><p><bold>eFigure.</bold> Flow Chart of Participants Included in the Analysis</p><p><bold>eTable.</bold> Comparison of Z-Score VO<sub>2max</sub> and VAT Across Subgroups of Patients and Controls</p></caption><media xlink:href="jamanetwopen-e2461795-s001.pdf"/></supplementary-material><supplementary-material position="float" content-type="local-data"><label>Supplement 2.</label><caption><p><bold>Nonauthor Collaborators.</bold> Quality of Life in Children With Inherited Cardiomyopathy or Arrhythmia (QUALIMYORYTHM) Study Group members</p></caption><media xlink:href="jamanetwopen-e2461795-s002.pdf"/></supplementary-material><supplementary-material position="float" content-type="local-data"><label>Supplement 3.</label><caption><p>
Data Sharing Statement
</p></caption><media xlink:href="jamanetwopen-e2461795-s003.pdf"/></supplementary-material></notes></back></article><!--requester-ID pruich-->